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The ending is nearer than you think, and it is already written. All that we have left to choose is the correct 
moment to begin. 
Alan Moore 
 
The present thesis entitled ‘Transcription Dynamics Prevent RNA-Mediated Genomic 
Instability through SRPK2-Dependent DDX23 Phosphorylation’ is divided into five 
major chapters with a short summary preceding it in both Portuguese and English. Each 
chapter is divided into smaller sections that explain an experiment or an idea. A general 
introduction to the topic of research has been dealt in Chapter 1 with a special emphasis 
on ‘R-loops and RNA processing factors’. The results obtained pertaining to this 
dissertation are presented as three individual chapters − Chapter 2, 3 and 4. The central 
idea of this project is to comprehend the molecular mechanisms employed by cells to 
sense, signal and resolve R-loops. Each of Chapter 2, 3 and 4 will describe the data 
related to SRPK2 – signal transducer, DDX23 – molecular effector and RNA Pol II – 
sensor for R-loops, respectively. Extended data table 1 − SRPK1 and SRPK2 ChIP-seq 
data and Extended data table 2 – DDX23 mutational analysis were attached in electronic 
format. A general scope of the work with implications in cancer has been discussed in 
Chapter 5. All the technical details and materials used related to this study has been 
elaborately mentioned at the end as Appendix A in order not to break the flow of the main 
text. Additionally, references, abbreviations and published articles were mentioned at the 
end from Appendices B-D. All the files pertaining to this thesis are attached in electronic 
format for further reference. This thesis is profusely filled with paraphrases and anecdotes 
that emphasize the meaning of a chapter in order to provide an organic reading.  
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Resumo 
Durante a transcrição, os transcritos de RNA são sintetizados pela RNA polimerase II 
(RNA Pol II) a partir da informação contida na cadeia de DNA. A síntese de RNA ocorre 
dentro da bolha de transcrição onde as duas cadeias de DNA são fisicamente separadas e o 
RNA nascente forma um híbrido RNA-DNA de aproximadamente 8 pares de bases com a 
cadeia molde. No entanto, a estrutura molecular da RNA Pol II assegura que o transcrito 
nascente seja fisicamente separado do DNA aquando da sua saída do local activo da 
enzima. Por esta razão, foi, até há pouco tempo, amplamente aceite que as estruturas 
híbridas de RNA-DNA seriam apenas produtos transientes da transcrição. Contudo, uma 
década de investigação demonstrou que híbridos de RNA-DNA se formam igualmente não 
é jusante da bolha de transcrição, originando, juntamente com cadeia de DNA 
desemparelhada, estruturas que se designam R-loops. Os R-loops são importantes para a 
regulação da dinâmica da transcrição e em diversos processos celulares, tais como a 
recombinação e a reparação de DNA. No entanto, os R-loops representam também uma 
grande ameaça à estabilidade genómica e devem por isso ser mantidos dentro de níveis 
fisiológicos. 
Em condições normais, as células regulam os níveis fisiológicos de R-loops 
através de enzimas como helicases de DNA/RNA e nucleases (como RNase H) de forma a 
separar ou digerir a fração de RNA dos R-loops, respetivamente, com o intuito de manter a 
conformação do DNA nativo. Além disso, são conhecidos vários fatores de processamento 
de RNA que impedem a formação de R-loops, sequestrando o RNA nascente e impedindo-
o de se ligar ao DNA, prevenindo assim a instabilidade genómica associada à formação de 
R-loops. Por exemplo, o fator de ligação SRSF1 é conhecido por prevenir a instabilidade 
genómica mediada por R-loops. Contudo, as cascatas de sinalização e as vias moleculares 
que conduzem à sua mobilização e ativação são essencialmente desconhecidas.  
A atividade de diversos fatores de processamento de RNA é regulada através da 
fosforilação que é, em muitos casos, conduzida por proteínas quinase de serina/arginina 
(SRPK) 1 e 2. Estas quinases fosforilam domínios de arginina-serina (SR) de vários fatores 
de processamento de RNA classificados como proteínas-SR e regulam a sua função. O 
ciclo de fosforilação e desfosforilação prejudica a regulação da função das proteínas-SR e 
a sua ligação atempada aos elementos reguladores cis do RNA nascente. No entanto, a 
função das SRPK1 e SRPK2 no metabolismo de R-loops e na estabilidade do genoma 
ainda não foi desvendada.  
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Neste trabalho identificámos uma nova função associada à proteína SRPK2 na 
prevenção da instabilidade genómica. Para além disso, verificámos que a instabilidade 
genómica observada na ausência de SRPK2 é um fenómeno dependente da transcrição, 
mais concretamente da formação de R-loops. Na procura da base molecular desta 
observação, identificámos a DDX23, uma helicase DEAD box com um domínio RS na 
porção N-terminal, como sendo o substrato da proteína SRPK2 responsável por prevenir a 
instabilidade genómica mediada por R-loops. Mostrámos que a perda individual destas 
duas proteínas resulta na acumulação de níveis elevados de R-loops, que posteriormente 
conduzem a quebras no DNA. Adicionalmente, células com depleção de SRPK2 e DDX23 
possuem aberrações cromossómicas condicentes com a elevada instabilidade genómica 
observada. O nosso trabalho revelou que a fosforilação da proteína DDX23 é necessária e 
suficiente para restaurar a estabilidade genómica em células com depleção de SRPK2 
através de um processo que envolve a sua função de helicase de RNA. Embora a proteína 
DDX23 faça parte do complexo ribonucleoproteíco U5 snRNP do spliceossoma, 
demonstrámos que o seu papel na supressão de R-loops não necessita de um U5 snRNP 
funcional, uma vez que a depleção de PRP8 ou PRP6, componentes principais de U5 
snRNP, não gera instabilidade genómica.  
De forma a investigar o processo através do qual a SRPK2 reconhecia a presença 
dos R-loops, fosforilando a DDX23 de modo a suprimi-los, identificámos a pausa da RNA 
Pol II promovida pelos R-loops como factor central neste mecanismo. Assim, na presença 
de um R-loop, a RNA Pol II pausa a sua elongação, o que denuncia a localização do R-
loop e promove o recrutamento de SRPK2 e a fosforilação da DDX23. Assim, este 
processo constitui um novo mecanismo zelador da integridade genómica que atua de forma 
a evitar danos no DNA que poderiam potenciar a formação de tumores. Suportando este 
modelo, observámos que a inexistência do locus do DDX23 é uma característica frequente 
no Carcinoma Adenóide Cístico, um cancro muito agressivo das glândulas salivares e com 
oportunidades de tratamento limitadas devido ao conhecimento incompleto da sua base 
genética e molecular. Em resumo, este trabalho permite-nos concluir que oscilações na 
dinâmica da RNA polimerase II constituem um sensor molecular de R-loops que pode 
prevenir eventos potencialmente catastróficos que inviabilizam a manutenção da 
estabilidade genómica.    
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Summary 
During transcription, RNA is synthesized by RNA polymerase II (RNA Pol II) using the 
information contained in the template DNA strand. RNA synthesis occurs inside the 
transcription bubble where the two strands of DNA are physically separated and the 
nascent transcript is hybridized to template strand through a ~8 base pair (bp) RNA-DNA 
hybrid. Latter, the molecular structure of the elongating RNA Pol II ensures that the 
nascent transcript leaves the transcription bubble physically separated from the template 
DNA. Therefore, it was widely believed that RNA-DNA hybrids were only transient by-
products of transcription. However, the past decade of research has shown those R-loops − 
RNA-DNA hybrids and a displaced single-stranded DNA−are abundant structures that 
play important roles in regulating gene expression and DNA recombination. Besides these 
physiological roles, R-loops also pose great threats to genome stability and should 
therefore be tightly regulated.  
Cells regulate the level of R-loops by employing enzymes like DNA/RNA 
helicases and nucleases to resolve the RNA moiety of R-loops. Additionally, various RNA 
processing factors are also known to prevent R-loop formation by sequestering the nascent 
RNA, thus preventing it from re-annealing to the template DNA. However, the signalling 
cascades and molecular switches that lead to the mobilization and activation of R-loop 
suppressors are essentially unknown.  
The activity of several RNA processing factors is regulated through 
phosphorylation, which in many cases is driven by serine/arginine protein kinases (SRPK) 
1 and 2.  These kinases phosphorylate the arginine-serine (RS) domain of various RNA 
processing factors classified as SR-proteins. Phosphorylation/de-phosphorylation cycles 
regulate the function of SR-proteins and the timely binding to cis regulatory elements on 
the nascent RNA. However, the roles of both SRPK1 and SRPK2 in R-loop metabolism 
and genome stability have not yet been investigated. Herein, we identify a new role for 
SRPK2 in preventing genomic instability through a mechanism involving the suppression 
of R-loops. We show that phosphorylation of the DEAD box helicase-DDX23 is necessary 
and sufficient to restore the genome stability in SRPK2-deficient cells through a process 
that requires its helicase activity.  
DDX23 is part of the spliceosomal U5 small nuclear ribonucleoprotein complex 
(U5 snRNP). We found that the role of DDX23 in suppressing R-loops does not require a 
functional U5 snRNP as depletion of either PRP8 or PRP6, core components of the U5 
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snRNP, does not drive genomic instability. Altogether, we found that phosphorylation of 
DDX23 by SRPK2 is a crucial event to maintain cellular R-loop levels, failure of which 
severely compromises genome integrity.  
Co-transcriptional R-loops impact on RNA Pol II transcription dynamics. For 
instance, they are involved in promoter-proximal pausing and promote efficient 
transcription termination by slowing down RNA Pol II facilitating the timely recruitment 
of termination factors. Here we describe a new pathway that employs oscillations in RNA 
Pol II dynamics as a molecular sensor to signal the location of R-loops and nucleate 
SRPK2-dependent DDX23 phosphorylation. This may constitute a new genome caretaker 
mechanism that would operate to ward off against tumour-driving DNA damage. 
Supporting this view, we observed that loss of DDX23 is a prevalent feature of adenoid 
cystic carcinoma, an aggressive salivary gland cancer with very limited treatment options 




























All these fifty years of conscious brooding have brought me no nearer to the answer to the question, 'What are 
light quanta?' Nowadays every Tom, Dick and Harry thinks he knows it, but he is mistaken! 
Albert Einstein 
 



















































 Genome instability is a hallmark of cancer. 
 R-loops are a major endogenous source of genome instability. 
 Defects in RNA processing machinery lead to unscheduled R-loop formation and 
genome instability. 
 Serine/arginine protein kinases 1 and 2 (SRPK1 and SRPK2) modulate the function 
of RNA processing factors. 
 
1.1 Genome instability is a hallmark of cancer 
Our DNA is constantly bombarded by various physical or chemical insults causing 
potential damage (Fig.1) (Helleday et al., 2014). Like, ultraviolet (UV) rays from sunlight 
are an example of a physical genotoxic agent. UV triggers photo-reactions in DNA that 
cause lesions like photo-products and/or pyrimidine dimers. A gross estimate suggests that 
10
5
 UV photo-products are generated in keratinocytes exposed on a sunny day (Ciccia and 
Elledge, 2010). These lesions alter the DNA structure and interfere with DNA replication 
and eventually cause mutations in the genome (Cleaver et al., 2003).  
DNA damage can also result from endogenous sources such as free radicals produced 
during normal cellular metabolism. Reactive oxygen and nitrogen species generated as 
metabolic by-products of general cell function can induce the formation of oxidative DNA 
products. Such products distort the DNA structure and threat genome stability eventually 
leading to spontaneous mutations and/or base loss in DNA (Ciccia and Elledge, 2010; 
Lindahl and Barnes, 2000).  
Approximately 10
5
 spontaneous DNA lesions can be experienced by every cell in one day 
(Hoeijmakers, 2015). Cells have to cope up with a constant threat to DNA and manage the 
damage that accumulates through time. However, the cumulative effect of various 
exogenous and endogenous sources of DNA damage challenges the genomic integrity 
beyond cells capability to handle such insults, leading to genome instability. Thus, 
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genomic instability can be defined as an increased propensity for genomic alterations 
(Shen, 2011; Aguilera and García-Muse, 2013) . 
Genome surveillance mechanisms ensure that the genome integrity is kept on check by 
detecting and resolving defects in the DNA and controlling the rate of spontaneous 
mutations. These surveillance mechanisms monitor the genomic integrity and push 
damaged cells to either arrest their cell cycle for further repair or to apoptosis (Jackson and 
Bartek, 2009). The genome surveillance machinery consists of caretakers that help in: a) 
detecting damaged DNA and signaling it to the repair machinery, b) repair of damaged 
DNA c) hindering further damage (Ciccia and Elledge, 2010). 
Cancer cells often augment the rate of mutations by increasing sensitivity to mutagenic 
agents concomitantly breaking down several components of the genome surveillance 
machinery (Jackson and Bartek, 2009; Liang et al., 2009). By doing so, cancer cells keep 
the cell cycle progression despite the presence of an unstable genome, thus acquiring 
mutations that in turn favor tumor progression (Shen, 2011). Accordingly, proteins 
involved in DNA repair pathways are mutated in several cancers leading to increased 
genome instability (Dietlein et al., 2014). In fact, abundant evidence suggests that genomic 
instability is instrumental for tumor progression, thus being classified as a ‘hallmark of 






















Figure 1. Genome instability is a hallmark of cancer. Various exogenous (e.g. X-rays from 
medical intervention, smoking and cosmic radiation) and endogenous sources (e.g. free radicals, 
activity of DNA polymerases (DNA Pol) and RNA Polymerases (RNA Pol)) constantly threat the 
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1.2 Transcription as an endogenous source of genome instability – a focus 
on R-loops 
During the first step of gene expression, the DNA is transcribed by RNA polymerase II 
(RNA Pol II) to make an RNA molecule. Such transcription takes place on the same 
physical template as DNA replication, DNA repair and DNA recombination thereby 
physically and functionally connecting DNA and RNA metabolism. Cells segregate these 
different pathways in space and time, failure of which may cause collisions between 
transcription and replication machinery leading to genome instability (Aguilera, 2002). 
Transcription also poses threat to genome integrity by opening of DNA duplex and making 
it accessible to mutagenic agents thereby increasing the propensity for mutations (Aguilera 
and García-Muse, 2012). Recent evidence also suggests a direct role of RNA Pol II in 
contributing for different genome instability events including hyper-recombination, DNA 
damage sensitivity and/or DNA double-strand breaks (DSBs) (Felipe-Abrio et al., 2014).  
Recent high-resolution cryo-electron microscopy of the transcribing RNA Pol II illustrates 
the interface between the nascent RNA and the template DNA within the polymerase 
where short RNA-DNA hybrids of ~8 base pairs (bp) are formed (Fig.2a) (Bernecky et al., 
2016; Cheung and Cramer, 2012). Elongating RNA Pol II ensures that nascent RNA is 
physically separated from the transcribed DNA, preventing the formation of extended 
RNA-DNA hybrids. However, transcription creates negative supercoiling upstream RNA 
Pol II, which provides a window of opportunity for nascent RNA to hybridize with the 
template DNA. In this scenario, the resulting three-stranded nucleic acid structure − 
consisting of an RNA-DNA hybrid and a displaced single stranded DNA (ssDNA) – is 
termed R-loop (Fig.2b) (Hamperl and Cimprich, 2014).  
Two models have been proposed for the formation of R-loops. The ‘extended RNA-DNA 
hybrid’ model, suggests that R-loops are basically an extension of the 8 bp RNA-DNA 
hybrid formed inside the elongating transcription bubble (Aguilera and García-Muse, 
2012; Skourti-Stathaki and Proudfoot, 2014). However, structural data strongly suggest 
that the exit channel for the nascent RNA allows for physical separation between RNA and 
DNA (Bernecky et al., 2016; Westover et al., 2004), suggesting that R-loops cannot be 
formed as a mere extension of the 8 bp RNA-DNA hybrid. Although physically separated, 
RNA does stay in close proximity to the template DNA, which may facilitate the re-
annealing of these two strands ‘outside’ the polymerase milieu, as proposed by the 
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alternative model for the formation of R-loops − the ‘thread back’ model.  The ‘thread 
back’ model proposes that the nascent RNA invades the template DNA upstream the 
elongating RNA Pol II (Aguilera and García-Muse, 2012; Chédin, 2016; Skourti-Stathaki 










Figure 2. Schematic view of an R-loop structure. a) Ribbon diagram of an RNA-DNA 
hybrid within an elongating RNA Pol II (gray), with RNA (red) and DNA (shades of 
blue). Note that the exit channel of nascent RNA is different from that of the DNA. 
Adapted from Cheung and Cramer, 2012.  b) Simple line diagram of an R-loop with RNA 
(red) annealed to the template strand of DNA (blue) and the displaced ssDNA (dark blue).  
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1.2.1 Biological roles of R-loops  
The past two decades of research revealed that R-loops play important roles in several 
processes such as gene expression, recombination and genome instability (Santos-Pereira 
and Aguilera, 2015). Insights into the role of R-loops in gene expression have been gained 
from genome-wide studies of R-loop occupancy (Chédin, 2016). This has been achieved 
by DNA-RNA immunoprecipitation followed by high-throughput sequencing (DRIP-seq). 
The basis of this technique is to pull down the RNA-DNA hybrids using a specific 
antibody and perform high-throughput sequencing of the immunoprecipitated nucleic 
acids.  
 
1.2.1.1 R-loops and transcription  
R-loops are widely distributed throughout the genome, with a tendency to localize at 
promoter and terminator regions of RNA Pol II-transcribed genes. They impact on RNA 
Pol II transcription dynamics at stages like promoter-proximal pausing and favor 
termination by slowing down RNA Pol II and facilitating the timely recruitment of RNA 
processing factors (Chan et al., 2014; Chen et al., 2015; Ginno et al., 2012; El Hage et al., 
2014; Wahba et al., 2016).  
 
1.2.1.1.1 R-loops and transcription activation  
About 60% of human gene promoters contain sequences that are enriched with cytosine-
guanine dinucleotides (known as CpG islands) (Jones, 2012). Cytosine methylation at 
promoter CpG islands is an epigenetic mechanism for transcription inhibition (Deaton and 
Bird, 2011). For instance, DNA methyltransferase 3B1 (DNMT3B1) silences gene 
expression by methylating promoter CpGs (Linhart et al., 2007). Interestingly, 
methylation-resistant CpG islands are characterized by strand asymmetry of guanines and 
cytosines (a feature termed GC skew). A positive GC-skew (a G-rich template DNA) is 
strongly correlated with increased R-loop formation at promoter proximal regions (Ginno 
et al., 2013). Notably, such R-loops block DNMT3B1-dependent silencing of gene 
expression by preventing  promoter CpG methylation (Fig.3a) (Ginno et al., 2012). These 
findings illustrate a role of R-loops that favors transcription initiation. 
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Another example of the role of R-loops in transcription initiation comes from the 
regulation of the human VIM locus (Fig.3b). Anti-sense transcription at the VIM locus in 
colon adenocarcinoma cells forms R-loops at the VIM promoter. These R-loops support the 
opening of the DNA duplex and decrease nucleosome occupancy, thus favoring the 
binding of transcription factors and activating transcription of the VIM gene (Boque-Sastre 
et al., 2015). A similar mechanism is observed in the budding yeast (S. cerevisiae) GAL 
gene cluster. The GAL gene cluster is a model to study inducible gene regulation in S. 
cerevisiae, where glucose (repressive) and galactose (active) have counter-acting roles in 
regulating GAL transcription. Notably, R-loops formed between the GAL long non-coding 
RNA and the GAL gene enhance GAL transcription in the presence of galactose (Cloutier 
et al., 2016). This is an interesting case suggesting a potential role of environmental cues 
(sugar in this case) as a trigger of R-loop mediated gene regulation.  
 
1.2.1.1.2 R-loops and transcription termination  
It is not yet clear how RNA Pol II transcription termination occurs, mainly because of the 
poor structural data available so far as a result of the transient nature of termination 
complexes (Hantsche and Cramer, 2016). However, two models have been widely 
accepted for RNA Pol II transcription termination. a) The “torpedo model” states that the 
5’-3’ exoribonuclease 2 (Xrn2/XRN2, Rat1 in yeast) digests the RNA fragments produced 
by RNA Pol II downstream of poly-adenylation sites (PAS) displacing RNA Pol II from 
the template strand through a torpedo-like event (Proudfoot, 1989, 2016). b) The 
“allosteric model” states that a conformational change in RNA Pol II elongating 
complexes post-PAS leads to termination (Epshtein et al., 2007; Rosonina et al., 2006). 
Additionally, the co-existence of both pathways was also suggested (Proudfoot, 2016).  
Genome-wide analyses revealed that some mammalian genes are enriched in G-rich pause 
elements immediately downstream of the PAS. These G-rich elements allow for the 
pausing of RNA Pol II giving time for Xrn2/XRN2 to cleave the nascent transcript (West 
et al., 2004). Notably, R-loops are preferentially enriched in human genes at 3’ ends with 
G-rich pause sites (Skourti-Stathaki and Proudfoot, 2014). Such R-loops regulate 
transcription termination by pausing RNA Pol II thus giving sufficient time for the 
recruitment of termination factors (Porrua et al., 2016). For example, the RNA/DNA 
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helicase − Senataxin (Sen1/SETX) is known to resolve R-loops formed at the gene 3’ end. 
By doing so, Sen1/SETX creates an entry point for Xrn2/XRN2 to access the RNA, 
facilitating RNA Pol II release as suggested by the torpedo model (Skourti-Stathaki et al., 
2011). Consistently in yeast, termination of RNA Pol II generated non-coding RNAs 
(ncRNAs) requires a termination complex (termination complex NRD; consisting of 
proteins Nrd1, Nab3 and Sen1 proteins) and cleavage factor (Pcf11 component of cleavage 
factor 1A) (Fig.3c) (Grzechnik et al., 2015). Interaction of the cleavage factor with the 
termination complex is mediated by the recruitment of Sen1. Ablation of Sen1 disrupts the 
termination-cleavage complexes and triggers R-loop formation (Grzechnik et al., 2015).   
Perturbations in such mechanisms might lead to termination defects letting RNA Pol II 
escape past transcription-termination region, a process termed transcription read-through. 
Notably, R-loops can also result from transcription read-through as observed in the Ube3a 
locus, where an R-loop formed in the anti-sense direction affects Ube3a gene expression. 
In this case, transcription read-through of Snord116 locus (located downstream of Ube3a) 
produces an anti-sense Ube3a RNA that inhibits sense Ube3a transcription forming a local 























Figure 3. R-loops affect transcription dynamics a) R-loops formed in human CpG island 
promoters repress methylation (red circles) of genes by preventing binding of DNA 
methlytransferase B1 (DNMT3B1). b) R-loops formed by anti-sense transcription of the VIM 
locus activates transcription in the sense direction by decreasing nucleosome occupancy and 
promoting transcription factor binding. c) Sen1 helicase and Rat1 nuclease work together with 
other termination factors (Nrd1, Pcf11) to terminate transcription in yeast. d) On the contrary, 
read-through of Snord116 locus in mouse cells forms R-loops in the anti-sense direction of the 
Ube3a locus thereby inhibiting sense transcription of Ube3a.  
Introduction 
 
                Chapter 1. 24 
 
1.2.1.2 Role of R-loops in chromatin dynamics and genome organization 
In addition to a role in gene expression, R-loops can also change the local chromatin 
structure and regulate the dynamic organization of the genome (Bernstein and Allis, 2005). 
For example, efficient pausing of RNA Pol II at the human β-actin (ACTB) locus is 
associated with the establishment of dimethylation of lysine 9 of histone H3 (H3K9me2) a 
repressive chromatin mark (Skourti-stathaki et al., 2014). The human ACTB has a G-rich 
pause site at its 3’ end where R-loops form both in sense and anti-sense direction (Skourti-
stathaki et al., 2014). Transcription in opposite direction makes two different RNAs that 
are complementary to each other resulting in the formation of local double-stranded RNA 
(dsRNA). Eventually, the dsRNA recruits the RNA interference (RNAi) machinery and 
histone-lysine N-methyltransferase 2 that seeds H3K9me2. All these events force RNA Pol 
II pausing allowing an efficient transcription termination (Skourti-stathaki et al., 2014). It 
turns out that H3K9me2 is also indispensable for C.elegans development by regulating R-
loop levels (Zeller et al., 2016). Similarly, in the fission yeast S. pombe, binding of 
ncRNAs to centromeric chromatin favors local heterochromatization a phenomenon 
mediated by R-loops with additional requirement of the RNAi machinery (Nakama et al., 
2012). Moreover, a prominent increase in condensed chromatin was reported in cells 
depleted of FAcilitates Chromatin Transcription (FACT) complex and Sen1/SETX in an 
R-loop dependent manner (Castellano-Pozo et al., 2013). 
Eukaryotic chromosomes (which are linear) have a problem in replicating their ends unlike 
bacterial chromosomes (that are circular). This “end-replication problem”, comes from the 
fact that chromosomes might lose information at their ends after every replication cycle 
(de Lange, 2009). This is where telomeric sequences come into action; these are repetitive 
sequences at the end of chromosomes that act as ‘buffers’ and prevent the loss of genetic 
material after each round of replication. Telomeres shorten as a function of time and 
therefore serve as indicators of cellular senescence. Telomerase is the enzyme that 
replenishes the recurrently shortening telomeres and prevents premature cellular 
senescence. Eukaryotic telomeres transcribe into non-coding telomeric-repeat-containing 
RNAs that hybridize with complementary telomeric DNA forming telomeric R-loops in 
yeast and human cells. R-loops at telomeric regions counteract the telomere shortening in 
both yeast and human cells that employ telomerase-independent pathways (Arora et al., 
2014; Balk et al., 2013; Pfeiffer et al., 2013a).  
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1.2.1.3 R-loops as drivers of genome instability 
On contrary to their function in regulating gene expression and chromatin dynamics 
unresolved R-loops pose great threats to the genome stability (Fig.4). Reasons for this are 
several: (a) RNA-DNA hybrids are thermodynamically more stable than double-stranded 
(dsDNA) (Thomas et al., 1976) adopting a conformation between the B-form of dsDNA 
and the A-form of dsRNA (Lesnik and Freier, 1995), making it hard for cells to resolve 
these hybrids. (b) Additionally, a RNA-DNA hybrid in an R-loop, displaces a ssDNA 
exposing it to DNA damage agents, such as nucleases and enzymes that cause DNA 
single-strand breaks (SSBs) (Paulsen et al., 2014; Sollier and Cimprich, 2015), which can 
eventually develop into DNA DSBs (Hatchi et al., 2015; Khoronenkova and Dianov, 
2015). (c) The R-loop potentially prevents nucleosome assembly and creates a damage-
prone ‘naked’ DNA region (Dunn and Griffith, 1980; Sollier and Cimprich, 2015). (d) R-
loops stall the transcription machinery, which can in turn block replication complexes 
causing transcription-replication collisions. In fact, hindrance of replication is thought to 
represent the most common cause of R-loop dependent DNA damage (Helmrich et al., 
2013). For instance, R-loops at immunoglobulin class-switch regions cause replication 
fork stalling and chromosomal rearrangements (Gaillard et al., 2015; Helmrich et al., 
2013).  
The role of R-loops in promoting DNA damage was first demonstrated in yeast and later in 
human cells lacking the TRanscription EXport complex (THO/TREX) (Domínguez-
Sánchez et al., 2011; Huertas and Aguilera, 2003). THO/TREX is a multi-protein complex 
involved in transcription and RNA export. Depletion of THO/TREX components leads to 
aberrant R-loop formation and DNA damage (Domínguez-Sánchez et al., 2011). 
Interestingly, C. elegans thoc-2 mutants exhibit replication-fork stalling and occurrence of 
DNA breaks, suggesting that thoc-2 mutants go through severe replication stress (Pfeiffer 
et al., 2013b, Castellano-Pozo et al., 2012, Santos-Pereira et al., 2014). Similarly depletion 
of RNA processing factors like serine/arginine splicing factor 1 (SRSF1, also known as 
ASF/SF2), Aquarius (AQR) and SETX challenges the genome integrity via R-loops (Li 
and Manley, 2005; Paulsen et al., 2014; Yüce-Petronczki and West, 2012).  
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Nevertheless, DNA damage itself can also lead to the formation of R-loops. For instance, 
DNA lesions within transcriptional units cause RNA Pol II pausing and local displacement 
of RNA processing factors, which create opportunities for DNA invasion by the nascent 
RNA and the resulting R-loop formation. Strikingly R-loops can also trigger the DNA 
damage response (DDR) creating a feedback loop between R-loops and the DDR (Tresini 
et al., 2015). Moreover, camptothecin, a topoisomerase I inhibitor that leads to RNA Pol II 
pausing and promotes R-loops also causes DNA damage (Baranello et al., 2009; Khobta et 
al., 2006; Liu et al., 1996; Marinello et al., 2013, 2016; Paulsen et al., 2014). This further 








Figure 4. R-loops are a major source of genome instability. R-loops pose great threat to genome 
integrity by interfering with RNA Pol II and DNA Pol creating transcription-replication collisions 
leading to double strand breaks (DSBs). Additionally, exposed ssDNA in a R-loop can act as a bait 
for DNA damaging enzymes and mutagenic agents creating single strand breaks (SSBs) that can 
eventualy frutify as DSBs. Further activity from Topoisomerases that try to relieve negative and 
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1.3 R-loops and disease 
Imbalance in R-loop homeostasis has been associated primarily with human neurological 
disorders and as a possible cause of genome instability in cancer cells (Fig.5).  
 
1.3.1 Role of R-loops in neurological disorders 
R-loops are implicated in the pathogenesis of neurodegenerative diseases like 
Amyotrophic lateral sclerosis (ALS), Aicardi-Goutières Syndrome (AGS) or Fragile X 
syndrome. Recent high-throughput R-loop sequencing in fibroblasts from AGS patients 
shows that R-loops are a source of unprocessed nucleic-acids burden seen in these cells 
(Lim et al., 2015). ALS is a severe debilitating neurodegenerative disease linked to 
mutations in various genes implicated in RNA metabolism (Hill et al., 2016; Salvi and 
Mekhail, 2015). Genetic and mutational studies helped to reveal connections between 
various ALS-linked factors and R-loop regulation (Groh and Gromak, 2014). Another 
neurological disease associated with R-loop biology is Fragile X syndrome and Fragile X-
associated tremor/ataxia syndrome (Colak et al., 2014; Groh et al., 2014). The reduced 
expression of the Fragile X mental retardation 1 (FMR1) gene containing CGG repeats in 
the 5’ UTR is the primary cause of the syndrome. Notably, FMR1 gene silencing is 
mediated by co-transcriptional R-loops formed at expanded CGG repeats (Groh et al., 
2014). 
R-loops tend to form in repetitive DNA sequences (like in ribosomal DNA and 
centromeric regions), because of the abundant complementarity between the nascent RNA 
and the template DNA (Nadel et al., 2015). For example, transcription of CTG repeat 
sequences leads to R-loop formation that stimulates repeat instability in bacteria and 
human cells (Lin et al., 2010; Reddy et al., 2011). Tri-nucleotide expansions might also 
impair transcription, as illustrated in Friedreich's ataxia, a common inherited ataxia. In 
Friedreich's ataxia unstable GAA repeat expansions in the first intron of the Frataxin gene 
reduce its expression by a mechanism involving the formation of R-loops and RNA Pol II 
stalling at the repeat sequences (Grabczyk et al., 2007; Reddy et al., 2011). Similarly, R-
loops formed in hexanucleotide repeat expansions-GGGGCC in the chromosome 9 open 
reading frame 72 are implicated in ALS (Haeusler et al., 2016).  
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Figure 5. Role of R-loops in human pathologies. R-loops play a crucial role in several 
neurological disorders (e.g. AGS, ALS and  Fragile X syndrome). Mutations in genes coding for 
proteins linked to R-loop homeostasis are frequently involved in the development of these 
neurological disorders. R-loops can also favor tumorigenic events that drive cancer progression 
and can contribute to the high levels of genome instability observed in most cancers. 
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1.3.2 Role of R-loops in cancer 
Evidence is gaining momentum to support the role of R-loop-mediated genome instability 
as a driver for cancer progression. For example, tumor suppressor genes like BRCA1 and 




 cells accumulate R-loops and DNA DSBs. However, how exactly BRCA1 
and BRCA2 regulate R-loop levels it still unclear. One mechanism BRCA1 employs to 
regulate R-loop levels is by orchestrating the mRNA splicing machinery and changing 
splicing patterns (Savage et al., 2014). On the other hand, BRCA2 is required to protect 
stalled replication forks and prevent their collapse, suggesting that BRCA2 might prevent 
R-loop accumulation by allowing replication fork to restart after cells clear R-loops (Berti 
and Vindigni, 2016). Malfunction of one or both of these proteins might increase the R-
loop burden in cancer cells triggering mutations favoring cancer progression.  
An interesting example of R-loop driven tumorigenic process is observed in Burkitt 
lymphoma, a cancer characterized by a translocation between the proto-oncogene Myc and 
immunoglobulin switch regions. Notably, the translocation sites are predominantly GC 
rich, a feature known to favor R-loop formation (Ramiro et al., 2004; Ruiz et al., 2011; 
Pefanis and Basu, 2015). Another example of the impact of R-loops in cancer development 
is the sequestration of the THO/TREX complex by the viral protein ORF75. Evidence 
suggests that this is a tumorigenic mechanism in cells infected with Kaposi’s-sarcoma-
associated herpes virus (Jackson et al., 2014). In fact, these cells accumulate increased R-
loops and genome instability. 
1.4 Cellular mechanisms to maintain R-loop homeostasis  
Cells accumulate R-loops naturally, but they also evolved various mechanisms to keep R-
loop levels constantly in check to prevent genome instability. Cellular mechanisms that 
maintain R-loop homeostasis fall into two major classes: a) those that prevent the 
















Figure 6. Molecular mechanisms to regulate R-loop homeostasis. Cells can regulate R-loop 
homeostasis by employing mechanisms to prevent de novo R-loop formation or resolving existent 
ones. RNA processing factors like serine-arginine splicing factor 1 (SRSF1), RNA transcription 
and export complex (THO/TREX) and other RNA processing machinery prevent R-loop formation 
by sequestering nascent RNA from binding to template DNA strand. Additionally, topoisomerases 
(eg., TOPO1) can also prevent R-loop formation by relieving the negative supercoiled DNA. Cells 
also employ ribonucleases H (RNase H) and DNA/RNA helicases like aquaris (AQR), senataxin 
(SETX) and other factors to either digest or resolve R-loops.  
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1.4.1 Mechanisms to prevent deleterious R-loops 
Cells can prevent R-loop formation by two possible mechanisms. 1) Stabilizing the native 
dsDNA conformation during replication and transcription and 2) coating the nascent RNA 
with proteins that physically obstruct the hybridization of RNA with DNA.  
Unwinding of the dsDNA during transcription generates positive DNA supercoils ahead 
and negative DNA supercoils behind the transcription complexes (Liu and Wang, 1987). 
This torsional strain is relieved by toposimerases during transcription (and replication) 
(Champoux, 2001; Lee and Young, 2000). As negatively supercoiled dsDNA is a critical 
factor for R-loop formation (Chédin, 2016) topoisomerases prevent co-transcriptional R-
loops by relieving negative supercoiled DNA behind elongating complexes (Yang et al., 
2014; Wilson-Sali and Hsieh, 2002). For instance, yeast topoisomerase 1 and 2 can 
regulate R-loops in ribosomal DNA, depletion of which increases R-loop levels and causes 
RNA polymerase I (RNA Pol I) stalling (El Hage et al., 2010). Similarly, topoisomerase I 
(TOPI) suppresses genomic instability in mammalian cells by preventing co-transcriptional 
R-loops and reduces conflicts between the transcription and replication machineries 
(Tuduri et al., 2009).  
A growing body of evidence suggests that RNA processing factors make a substantial 
contribution in maintaining R-loop homeostasis by preventing hybridization between the 
nascent RNA and the template DNA (Montecucco and Biamonti, 2013). Most of the RNA 
processing (i.e., capping, splicing, polyadenylation and folding) takes place co-
transcriptionally (Bentley, 2014). RNA processing proteins bind to nascent RNA forming a 
ribonucleoprotein (RNP) complex. In such a secluded environment, the nascent RNA is 
physically forbidden to invade the template DNA and form an R-loop. Therefore, 
deficiency of RNA processing factors and/or RNP biogenesis leads to R-loop formation. 
For instance, depletion of the already mentioned THO/TREX causes the accumulation of 
R-loops (Domínguez-Sánchez et al., 2011; Huertas and Aguilera, 2003; Pfeiffer et al., 
2013a). Actually, this illustrates the first link established between RNP biogenesis and R-
loop formation (Santos-Pereira and Aguilera, 2015). Depletion of the splicing factor 
SRSF1 in both chicken DT-40 and HeLa cells also induces R-loop-mediated genome 
instability possibly by perturbing RNP formation (Li and Manley, 2005; Paulsen et al., 
2014). Thus, the dynamics of co-transcriptional RNP formation is a critical determinant of 
R-loop homeostasis. Importantly, recruitment of the RNA-binding proteins, such as the 
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spliceosome components, to the nascent RNA, but not the process of splicing itself is 
critical to prevent R-loop formation and genome instability (Bonnet et al., 2017). 
 
1.4.2 Mechanisms to resolve deleterious R-loops  
To restore the native conformation of the duplex DNA, cells have to either digest or 
unwind the RNA moiety of an R-loop. For this purpose cells use nucleases or helicases, 
enzymes that either digest or unwind RNA from the R-loop, respectively (Sollier and 
Cimprich, 2015). Perhaps the most widely characterized nuclease that digests RNA within 
an R-loop is ribonuclease H (RNase H). Unlike other ribonucleases, RNase H specifically 
digests RNA that is hybridized to DNA (Schultz and Champoux, 2008). Two types of 
RNase H enzymes are present in eukaryotes: RNase H1 and RNase H2. Both types of 
RNase H enzymes can digest RNA from R-loops, although they have different 
physiological roles (Schultz and Champoux, 2008). RNase H1 is located in the nucleus and 
in mitochondria of mammalian cells, and digests R-loops that arise from nuclear and 
mitochondrial transcription (Cerritelli et al., 2003). RNase H2 digests RNA in RNA-DNA 
hybrids formed during replication (Sparks et al., 2012). RNase H2 can also remove single 
ribonucleotide moieties mis-incorporated in DNA, whereas RNase H1 works on longer 
patches of RNA-DNA hybrids (Zimmer and Koshland, 2016). Nevertheless, both enzymes 
are required for cellular survival. In agreement, Rnaseh1 null mice exhibit embryonic 
lethality (Cerritelli et al., 2003). Moreover, both depletion or constitutive activation of 
these enzymes is deleterious to cell survival, revealing the importance of a tight regulation 
of their cellular levels (Cerritelli and Crouch, 2009). For instance, deletion of RNase H1 
stabilizes RNA-DNA hybrids around DNA DSB sites impairing recruitment of the 
homologous recombination machinery (Ohle et al., 2016). On the other side, 
overexpression of RNase H1 destabilizes hybrids and leads to severe loss of repetitive 
regions around DSBs (Ohle et al., 2016). Furthermore, mutations in RNase H2 are strongly 
correlated with high levels of R-loops in fibroblasts from AGS patients (Lim et al., 2015). 
Besides RNase H, cells can employ RNA/DNA helicases to unwind RNA from R-loops 
allowing DNA to re-anneal into a dsDNA (Costantino and Koshland, 2015). RNA/DNA 
helicases like SETX, bacterial RecG DNA helicase, Rho transcription termination factor, 
yeast DNA helicase Pif1, human RNA helicase DEAH box protein 9 and human RNA 
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helicase aquarius (AQR) have all been shown to maintain R-loop homeostasis 
(Harinarayanan and Gowrishankar, 2003; Hong et al., 1995; Paulsen et al., 2014). As 
already mentioned, depletion of the RNA/DNA helicase SETX leads to increased 
occurrence of R-loops in transcription termination sites (Becherel et al., 2013; Kim et al., 
1999; Mischo et al., 2011; Skourti-Stathaki et al., 2011). The DEAH box protein 9 was 
shown to specifically resolve R-loops structures in vitro (Chakraborty and Grosse, 2011). 
In addition, yeast Pif1 helicase might reduce R-loop levels by destabilizing G4 DNA (G 
quadruplexes or G quadrets) structures allowing duplex DNA formation (Boué and Zakian, 
2007; Mendoza et al., 2015). G4 DNA is a tertiary nucleic acid structure formed in 
guanine rich regions. A minimum of 4 guanine bases can form a square planar structure 
through hoogsten pairing called a guanine tetrad. Two or more guanine tetrads stack on top 
of each other to form a G4 DNA (Maizels and Gray, 2013). Interestingly, R-loops tend to 
form with transcription of C-rich template DNA forming a G-rich RNA and displacing a 
G-rich ssDNA (Ginno et al., 2013). Such, G-rich ssDNA is likely to form a G4 structures 
(Sollier and Cimprich, 2015). Therefore, helicases like yeast Pif1 that relieve G4-DNA on 
ssDNA can indirectly regulate R-loop levels. However, despite their established role in 
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Figure 7. SRPKs at the centre of cancer-related mechanisms and RNA processing.  a) SRPK1 
and SRPK2 phosphorylate various SR proteins that play critical role in different steps of RNA 
processing such as splicing and export. Adapted from Varjosalo et al., 2013. b) SRPKs lie at the 
centre of alternative aplicing decisions that are detrimental for various cellular processes like 
proliferation, growth and apoptosis. Dysregulation of SRPKs changes splicing patterns promoting 
cancer development. Adapted from Oltean and Bates, 2013. 
1.5 SRPK1 and SRPK2 as central modulators of RNA processing factors 
Protein phosphorylation is a master regulatory mechanism that operates in virtually all 
cellular processes, including RNA processing or the DDR. For instance, during the DDR, 
phosphorylation impacts on the localization, stability and activity of several proteins, 
acting as signal cues to sense, transduce and repair the DNA lesion. In fact, 900 
phosphorylation events involving about 700 proteins are estimated at the onset of the DDR 
(Matsuoka et al., 2007). These numbers emphasize the important role of protein kinases 
(Lahiry et al., 2010) with a special function in maintaining genome stability (Jackson and 
Bartek, 2009). In addition, recent proteomic study revealed that serine/arginine protein 
kinases (SRPKs; that include SRPK1 and SRPK2) are required to orchestrate distinct 
molecular events involved in RNA processing (Varjosalo et al., 2013). Indeed, a major 
fraction of SRPK1 and SRPK2 substrates have roles related with transcription and RNA 
processing (Fig.7a). These substrates range from splicing factors to several helicases 
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1.5.1 Functions of SRPK1 and SRPK2 
SRPK1 and SRPK2 share a sequence homology of ~57%, but have distinct roles by 
modulating splicing decisions of crucial biological functions (Fig.7b) (Wang et al., 1998). 
For instance, chemical inhibition of SRPK1 or SRPK1 RNAi was found to effectively 
block angiogenesis by changing the alternative splicing pattern of vascular endothelial 
growth factor (a pro-angiogenic molecule) (Amin et al., 2011). Additionally, the C. 
elegans orthologue of SRPK1 and human SRPK1 are essential for embryogenesis of C. 
elegans and spermatogenesis, respectively (Galvin et al., 2011; Papoutsopoulou et al., 
1999). However, SRPK2 plays an important role in regulating alternative splicing in 
response to DNA damage in neuronal cells (Vivarelli et al., 2013; Wang et al., 1998). 
While SRPK1 is part of the U1 small nuclear ribonucleoprotein (U1 snRNP) complex of 
the splicing machinery, SRPK2 is part of the U4/U6.U5 tri-snRNP spliceosomal complex 
(Kamachi et al., 2002; Mathew et al., 2008). Both play crucial roles in constitutive and 
alternative splicing. As the name suggests, SRPK1 and SRPK2 phosphorylate serine 
residues of serine/arginine rich proteins (SR proteins), a group of proteins bearing a 
arginine/serine (RS) domain either in their N or C terminus (Zhou and Fu, 2013). SRPKs 
can phosphorylate up to 8 serines in the RS domain using a processive mechanism in 
which the kinase stays attached to the substrate after each round of phosphorylation. The 
remaining serines in the RS domain are modified in a distributive manner in which the 
kinase and substrate dissociate after each phosphorylation event. SRPKs tend to have a 
preference for serines adjacent to arginines, rather than threonines (Ghosh and Adams, 
2011; Stojdl and Bell, 1999). 
SR proteins have diverse roles in cellular process like cell signaling, cell cycle progression 
and notably RNA and DNA metabolism (Giannakouros et al., 2011). SR proteins that play 
a role in RNA processing have a RS domain and one or more RNA binding motifs (Sapra 
et al., 2009). The RS domain drive protein-protein interactions, which in turn facilitate the 
appropriate binding of the RNA binding motifs to cis-regulatory elements of pre-
messenger RNA (pre-mRNA) (Manley and Tacke, 1996). The RS domain of spliceosomal 
SR proteins is profusely phosphorylated and the splicing activity is significantly dependent 
on the degree and timing of the phosphorylation event (Cazalla et al., 2002). In vitro and in 
vivo studies strongly suggest that the phosphorylation/de-phosphorylation switch leads to 
changes in the protein interaction milieu of the spliceosome and affects splicing (Long and 
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Caceres, 2009; Stojdl and Bell, 1999; Xiang et al., 2013). Thus, SRPK-mediated 
phosphorylation of SR proteins plays a crucial role in processing nascent RNA.  
 
1.5.2 Regulation of SRPK1 and SRPK2 
SRPK1 and SRPK2 are conserved kinases found in yeast, worms, slime molds, plants and 
mammals. Structurally they have a typical bilobal domain found in all eukaryotic protein 
kinases separated by an insert domain (Ghosh and Adams, 2011). The insert domain is 
important in regulating the sub-cellular localization and in turn the function of SRPK1 and 
SRPK2. The insert domain acts as a docking site for the binding of chaperone proteins 
(Zhong et al., 2009). In mammalian cells, different environmental cues and stress signals 
affect SRPKs sub-cellular localization by regulating the binding of chaperone proteins to 
the insert domain (Ghosh and Adams, 2011).  
Additionally, the function of SRPK1 and SRPK2 is regulated by post-translational 
modifications. For instance, protein kinase B (AKT) mediated threonine-492 
phosphorylation of SRPK2 promotes its nuclear translocation leading to cyclin D1 up-
regulation and cell cycle re-entry of neuronal cells leading to their apoptosis (Jang et al., 
2009). AKT is the only known upstream kinase of SRPKs and creates diversity in SRPK1 
and SRPK2 functionality. While AKT-SRPK2 axis works in regulating neuronal 
apoptosis, AKT-SRPK1 axis regulates alternative splicing decisions in angiogenesis of 
gliomas and in malignancy of hepatocellular carcinoma (Wang et al., 2014; Wu et al., 
2014; Zhou et al., 2013). The 14-3-3 protein counteracts AKT phosphorylation of SRPK2 
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1.5.3 Role of SRPK1 and SRPK2 in human malignancies 
Mutations and differential expression of SRPKs have been observed in various diseases 
like cancer, neurological pathologies and viral infections (Giannakouros et al., 2011).  
 
1.5.3.1 SRPKs in cancer 
A recent phospho-proteomic screen in head and neck squamous cell carcinoma cells 
identified a hyperphosphorylated form of SRPK2 regulating splicing patterns 
(Radhakrishnan et al., 2016). Inhibition of SRPK2 significantly decreased the colony 
forming capability of head and neck squamous carcinoma cells. Additionally, SRPK2 and 
SR-like protein acinus are overexpressed in some human acute myelogenous leukemia 
patients. Phosphorylation of acinus by SPRK2 elevates cyclin A1 expression levels and 
increase leukemia cell proliferation (Hong et al., 2011; Jang et al., 2008). In non-small cell 
lung cancer, the ectopic expression of SRPK1 promotes the growth and migration of 
cancer cells, whereas SRPK1 knock-down inhibits tumor growth, migration, and 
tumorigenicity (Liu et al., 2016). Upregulation of SRPK1 was also correlated with high 
metastasis rates and poor survival in breast cancer patients (Lin et al., 2014; Wang et al., 
2014).  
Additionally, SRPKs have been implicated in viral pathologies. For instance, the SRPK 
inhibitor SRPIN340 suppresses hepatitis C virus replication in vitro in a dose-dependent 
manner (Karakama et al., 2010). Additionally, phosphorylation of the SR splicing factor 4 
by SRPK2 increased to 20-fold under infection. Chemical inhibition of SRPK1 and 
SRPK2 using SRPIN340 inhibited viral replication (Fukuhara et al., 2006) suggesting that 
SRPKs lie at the heart of the host splicing machinery hijacked by viruses. However, it is 
still not clear if SRPKs play a role in viral induced tumorigenic process 
 
1.5.3.2 SRPKs in neuronal pathologies 
A growing body of evidence has implied SRPKs in neuronal pathologies (Chan and Ye, 
2013). For instance, threonine 492-phosphorylated SRPK2 binds 14-3-3 protein and 
triggers cell cycle progression and cell death in terminally differentiated neurons (Jang et 
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al., 2009). Additionally, phosphorylation of Tau by SRPK2 was linked to Alzheimer’s 
disease (Hong et al., 2012). Tau proteins are soluble microtubule-associated proteins 
expressed specially in neuronal cells. Deregulation of Tau are causally linked to 
Alzheimer’s disease and other neuronal degeneration (Ballatore et al., 2007), suggesting a 
role of SRPK2 in additional neuronal pathologies. SRPK1, but not SRPK2, translocates 
from the nucleus into the cytoplasm under ischemic stress in neurons (Erdö et al., 2004). 
This differential behavior may relate with the findings of an anti-apoptotic role of SRPK1 
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1.6 Open questions  
Despite the already known role in splicing, the role of SRPKs in regulating the genome 
stability (a hallmark of cancer) is yet to be elucidated. We therefore asked the following 
questions: 
1) Do SRPKs have any role in maintaining R-loop mediated genome stability?  
 
Rationale: This question stems from the fact that the proper functioning of RNA 
processing factors (many of them are SR proteins) is crucial to maintain cellular R-
loop levels.  
 
Hypothesis: We hypothesize that SRPKs regulate R-loop levels by fine tuning the 
function of several RNA processing factors. 
 
2) How do SRPKs regulate R-loop homeostasis?   
 
Rationale: Various RNA binding proteins and RNA/DNA helicases are substrates 
of SRPKs anticipating a putative role of SRPK–dependent phosphorylation in 
maintaining R-loop homeostasis. 
 
Hypothesis: We hypothesize that SRPKs regulate R-loop levels by driving the 
phosphorylation of RNA processing factors. Failure of SRPKs activity might lead 
to aberrant processing of the nascent RNA transcript and trigger R-loop formation. 
SRPKs may balance R-loop levels by either preventing the formation of deleterious 
R-loops or by driving the resolution of the existing ones.  
 
3) Is the link between SRPKs and R-loop mediated genome instability relevant for 
cancer development? 
 
Rationale: Both SRPK1 and SRPK2 are mutated in several cancers such as breast, 
colon, pancreas, head/neck and leukemia.   
 
Hypothesis: We hypothesize that SRPKs are major regulators of cellular R-loop 
levels and the genetic inactivation of SRPKs drives tumorigenic processes.  
 
Goal 
The main goal of this thesis is to provide mechanistic insights into each of the 









































A single twig breaks, but the bundle of twigs is strong. 
Tecumseh 
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Highlights 
 SRPK1 and SRPK2 are associated with RNA Pol II complexes. 
 Depletion of SRPK2 induces DNA damage. 
 R-loops are the major source of DNA damage in SRPK2-depleted cells. 
 
 
2.1 SRPK2 is necessary to protect the genome integrity 
SRPK1 and SRPK2 orchestrate the phosphorylation of several SR proteins acting as RNA 
processing factors. As RNA processing factors play a critical role in maintaining genome 
stability (Paulsen et al., 2009) we asked whether SRPKs function to prevent DNA damage. 
To gain novel insights into the biological function of SRPK1 and SRPK2 in DNA damage, 
we depleted either SRPK1 or SRPK2 from U-2OS and HeLa cells by RNAi and measured 
the amount of resulting DNA damage by immunofluorescence (Fig.8a) and western blot 
(Fig.8b) of phosphorylated histone H2AX (γH2AX) – an hallmark of the DNA damage 
response to DNA DSBs, here used as a proxy for DNA damage. SRPK1 and SRPK2 were 
depleted using different pools of small interfering RNAs (siRNA). As a control we 
included a pool of siRNA directed against firefly luciferase gene. Following the depletion 
of SRPK2, but not of SRPK1, there was a significant increase in total cellular γH2AX 
levels (Fig.8b). Additionally, we also observed a striking increase in nuclear γH2AX foci 
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Figure 8. SRPK2 is necessary to maintain the genome integrity. a) γH2AX foci (green) and 
cyclin A (red) staining in control, SRPK1 and SRPK2 RNAi-depleted U-2OS cells. Means and 
standard deviations of the percentage of cells with 10 or more γH2AX foci were plotted. At least 100 
cells from three independent experiments were scored. Scale bars:10 μm. Statistical significance was 
determined using two-tailed Student’s t-test *p<0.05. b) Immunoblots showing γH2AX, SRPK1 and 
SRPK2 levels in U-2OS cells upon depletion of SRPK1 or SRPK2 by RNAi. Histone H2B and α-
tubulin served as loading controls. Molecular weight markers (KDa) are shown on the left. Data are 
representative of three independent experiments. c) Immunoblots showing γH2AX, SRPK1 and 
SRPK2 levels in HeLa cells upon depletion of SRPK1 or SRPK2 by RNAi. Histone H2B and α-
tubulin served as loading controls. Molecular weight markers (KDa) are shown on the left. Data are 
representative of three independent experiments. 
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2.2 RNA Pol II acts as a molecular bridge for the association of SRPK1 
and SRPK2 to chromatin  
Within the cell, SRPK1 and SRPK2 can be detected both in the cytoplasm and in the 
nucleus where they adopt a speckles-like distribution pattern, which is typical of splicing 
proteins (Fig.9a). Additionally, we also observed both SRPK1 and SRPK2 in the 
nucleoplasm and associated with chromatin as revealed by sub-cellular fractionation 
(Fig.9b). Intrigued by the chromatin association of SRPKs, we reasoned that either RNA 
Pol II or the RNA transcript served as a linker between SRPKs and chromatin.  
In order to inspect the role of RNA in bridging SRPK1 and SRPK2 to chromatin we 
isolated chromatin from RNase A-digested nuclei. Digestion of nuclear RNA using RNase 
A before chromatin isolation released the RNA-bound U1-A30K (splicing factor) from the 
chromatin. U1-A30K acted as control for RNase A digestion. We observed that the RNase 
A digestion did not perturb the interaction of SRPK1 and SRPK2 with chromatin, 
suggesting an RNA-independent interaction (Fig.9c).  
We then reasoned that SRPKs could be tethered to chromatin via RNA Pol II. We further 
hypothesize that the C-terminal domain (CTD) of RNA Pol II largest subunit RPB1 is 
directly implicated in the interaction with SRPKs. The RNA Pol II CTD consists of 
multiple repeats of the YSPTSPS heptad, varying in number from 26 in yeast to 52 in 
human. The RNA Pol II CTD is subject to extensive post-translational modification, 
notably phosphorylation, during the transcription cycle. The RNA Pol II CTD also acts as 
a molecular platform to recruit multiple RNA processing factors during transcription (de 
Almeida and Carmo-Fonseca, 2012; Zaborowska et al., 2016; Harlen et al., 2016). To this 
end, we immunoprecipitated endogenous SRPK1, SRPK2 and RNA Pol II from isolated 
nuclear extracts (Fig.9e). Further, DNase I digestion was performed to exclude DNA that 
might act as linker between SRPKs and RNA Pol II (Fig.9d). This experiment revealed 
that both SRPK1 and SRPK2 are associated with RNA Pol II complexes, suggesting that 
RNA Pol II act as a molecular bridge that brings SRPKs to chromatin (Fig.9e).  
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Figure 9. SRPK1 and SRPK2 are chromatin associated proteins. a) Immunofluorescence 
analysis of endogenous SRPK1 and SRPK2 in U-2OS cells. Scale bars: 10 μm. b) Immunoblots 
showing SRPK1 and SRPK2 levels in cytoplasm (Cyto), nucleoplasm (Nucleo) and chromatin 
(Chrom) biochemical fractions of U-2OS cells. α-tubulin, U2AF
65
 and histone H2B immunoblots 
served as controls for independent fractions. Data are representative of three independent 
experiments performed. c) Immunoblots showing the SRPK1 and SRPK2 levels in the nucleoplasm 
(Nucleo) and chromatin (Chrom) fractions treated with/without RNase A in HeLa cells. U1A-30K 
and histone H3 immunoblots served as controls for RNase A treatment and fractionation protocol 
respectively. Molecular weight markers (KDa) are shown on the left. Data are representative of three 
independent experiments performed. d) Genomic DNA from MCF7 cells run on 1% agarose gel 
with (+) and without (-) DNase I digestion. Note that DNase I digests genomic DNA to ~100bp 
fragments. 1Kb plus DNA ladder are shown on the left in base pairs. e) Immunoprecipitations of 
SRPK1, SRPK2 and RNA Pol II in MCF7 cells nuclear extracts. Purified complexes were resolved 
by SDS-PAGE and blotted with antibodies against SRPK1 and SRPK2. The Input lane represents 
10% total cell lysates and IgG IP denotes the negative control immunoprecipitation. Molecular 
weight markers (KDa) are shown on the left. Data are representative of three independent 
experiments. 
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Figure 10. Transcription inhibition prevents the genome instability in SRPK2-depleted cells. a) 
γH2AX foci (green) and cyclin A staining (red) in control, SRPK1 and SRPK2 RNAi depleted U-
2OS cells with and without triptolide treatment (to inhibit transcription). Scale bars: 10μm. b) Means 
and standard deviations of the percentage of cells with 10 or more γH2AX foci are plotted. At least 
100 cells from three independent experiments were scored. c) same as in (b) but for cyclin A-
positive cells only. All statistical significance was determined using two-tailed Student’s t-test 
*p<0.05. d) Cell cycle progression of control and triptolide treated U-2OS cells were obtained by 
flow cytometry analysis of propidium iodide staining. Data shown are from one representative 
experiment.  
Given the association of SRPK1 and SRPK2 with RNA Pol II, we then asked, if inhibition 
of transcription could interfere with the DNA damage observed in SRPK2-depleted cells. 
To this end, we inhibited RNA Pol II transcription initiation using triptolide (Titov et al., 
2011). Indeed, inhibition of transcription reduced the number of nuclear γH2AX foci in 
SRPK2-deficient cells (Fig.10a-c). The 70 minutes incubation time with triptolide in our 
experimental setting did not produce any noticeable cell cycle alterations (Fig.10d) 
suggesting that the effect on DNA damage is driven by the transcription inhibition. This 
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After confirming the association of SRPKs with chromatin, we proceeded to perform 
chromatin immunoprecipitation followed by deep sequencing of the isolated DNA (ChIP-
seq) to identify their whole-genome occupancy. We followed the ENCODE guidelines 
(Landt and Marinov, 2012) to test the specificity of SRPK1 and SRPK2 antibodies 
(Fig.11a) and fragmenting DNA to ~100-300 bp (Fig.11b). The SRPK1 and SRPK2 
distribution along selected individual genes (Fig.11c) was validated by ChIP-qPCR 
(Fig.11d,e) with the same antibodies used for ChIP-seq. 
 
The genome-wide chromatin distribution of both SRPKs revealed that they nucleate 
preferentially in protein coding genes (Fig.12a). While SRPK1 is enriched at the promoter 
region, SRPK2 is distributed more evenly across the entire gene. Both kinases were 
preferentially detected at longer genes, but gene expression levels or GC content did not 
influence their chromatin binding (Fig.12b,c). However, we observed a strand asymmetry 
in the distribution of G and C residues (GC skew) in the vicinity of SRPK peaks (Fig.12c). 
Since GC skew is a predictor of R-loop formation (Ginno et al., 2013, 2012; Sanz et al., 
Figure 11. SRPK1 and SRPK2 ChIP-seq validation. a) Immunoblots showing SRPK1 and 
SRPK2 levels in transiently transfected with SRPK1 and SRPK2 siRNAs. α-tubulin served as 
loading control. b) Input DNA samples collected for ChIP-seq analysis were run on 1% agarose gel. 
Note that inputs from two biological replicates (1 and 2, including independent technical replicates) 
were run on gel to show that most of the DNA is about 100-300 bp fragments. 1 Kb plus DNA 
ladder are shown on the left in base pairs. c) Individual profiles of SRPK1 (blue) and SRPK2 (red) 
with respective duplicates at candidate gene loci. ChIP analysis of SRPK1 (d) and SRPK2 (e), data 
normalized against respective input samples. 
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2016) we wondered whether aberrant accumulation of R-loops drives the genomic 





Figure 12. SRPK1 and SRPK2 occupy intragenic chromatin regions that are prone to R-loop 
formation. a) Metagene analysis of SRPK1 and SRPK2 genome-wide average profiles. The average 
ChIP-seq signal (RPKMs) of two biological replicates is shown for each kinase. The gene body 
region was scaled to 100 equally sized bins and ± 10 Kb gene-flanking regions were averaged in 250 
bp windows. b) Gene Length (log10) and expression from GRO-seq (log2 TPMs) for all genes 
(gray); genes with SRPK2 (red) and SRPK1 (blue) enriched regions. c) Metaprofiles of SRPK1, 
SPRK2 enriched regions and random peaks dataset showing: read density (RPKMs, black solid line 
for ChIP and dashed line for input); GC-skew (red); CpG island (green); GC% (blue). Features were 
aggregated for 50 bp sliding windows of 1 bp step size. 
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Figure 13. R-loops are the major source of genome instability in SRPK2-depleted cells. a) 
γH2AX foci (green) in control, SRPK1 and SRPK2 RNAi-depleted cells transiently transfected with 
an RNaseH1-mCherry expression plasmid. Means and standard deviations of the percentage of cells 
with ≥10 γH2AX foci are plotted on the right-hand side. Note that the apparent increase in the % of 
control cells with γH2AX foci upon RNase H1 overexpression (red) is not statistically significant. 
Data are from a minimum of 100 cells scored in four independent experiments. Scale bar: 10 μm. All 
statistical significance was determined using two-tailed Student’s t-test. *p<0.05 b) Immunoblots 
showing γH2AX, RNase H1 (α-GFP), SRPK1 and SRPK2 levels in SRPK1 and SRPK2 RNAi-
depleted U-2OS cells that were transiently transfected with RNaseH1-GFP. Histone H2B and α-
tubulin served as loading controls. Molecular weight markers (KDa) are shown on the left. Data are 
representative of three independent experiments. c) Cell cycle progression of control and RNaseH1-
GFP expressed U-2OS cells was obtained by flow cytometry analysis of propidium iodide staining. 
Data are from one representative experiment of a total of three independent experiments performed. 
2.3 SRPK2 prevents RNA-mediated genome instability 
To test the contribution of R-loops in triggering the genome instability observed in 
SRPK2-depleted cells, we expressed RNase H1 exogenously in U2-OS cells depleted of 
each of the two kinases. Exogenenous expression of RNase H1 is a classical way to 
suppress R-loops in cells (Bhatia et al., 2014; Paulsen et al., 2014; Skourti-Stathaki et al., 
2011). This experiment revealed that RNase H1 overexpression rescued the DNA damage 
phenotype obtained upon SRPK2-depletion as revealed by decreased nuclear γH2AX foci 
in RNase H1-positive cells (Fig.13a). RNase H1 overexpression also reduced the total 
cellular γH2AX levels upon depletion of SRPK2, as revealed by western blot (Fig.13b). 
Additionally, ectopic expression of RNase H1 does not affect cell cycle profile within the 
time frame of our experimental setup indicating that the effect on DNA damage is not the 
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Figure 14. R-loops accumulate in SRPK2-depleted cells. Immunofluorescence analysis of R-loops 
obtained with the S9.6 antibody in control and SRPK2 RNAi-depleted cells. The nucleoplasmic 
intensity of the S9.6 staining (green) is plotted on the right-hand side. At least 100 cells from three 
independent experiments were scored. Scale bar: 10 μm.  Statistical significance was determined 
using Mann-whitney test. ***p<0.0005 
 
To directly inspect if R-loops accumulate in SRPK2-depleted cells we used the S9.6 
antibody, which specifically detects RNA-DNA hybrids in a sequence independent manner 
(Boguslawski et al., 1986), in immunofluorescence experiments. We observed a robust 
accumulation of nuclear R-loop levels in cells devoid of SRPK2 as revealed by the 
increased nucleoplasmic (non-nucleolar) signal obtained (Fig.14). We also observed a 
strong R-loop signal in nucleoli and in the cytoplasm, which is most likely the result of 
ribosomal DNA transcription and mitochondrial DNA replication, respectively (Brown et 
al., 2008; El Hage et al., 2010). Altogether these data implicate SRPK2 in a novel 
mechanism that is necessary for co-transcriptional R-loops suppression and in 

























































And they call to let you know your friend is dead in a box, 
The crows have the tools to get the meat out of the box, 
Scientific, ritualistic, headstone cold foxes still rot. 











The DEAD box helicase DDX23  
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Highlights 
 DDX23 (DEAD box helicase 23) is a specific substrate of SRPK2. 
 Phosphomimetic form of DDX23 rescues DNA damage in SRPK2-depleted cells. 
 DDX23 helicase suppresses RNA-mediated genome instability. 
 
3.1 SRSF1 does not rescue DNA damage in cells lacking SRPK2 
Based on the data discussed in Chapter 2, it is apparent that SRPK2 is necessary to 
regulate cellular R-loop levels. We then sought to investigate the molecular mechanisms of 
this regulatory activity. We first searched the literature for substrates that SRPK2 
phosphorylates. Amongst these substrates, SRSF1 emerged as a good candidate, because 
of its already known role in suppressing R-loop-driven DNA damage (Li and Manley, 
2005; Paulsen et al., 2014).  SRSF1 is a canonical splicing protein that belongs to the 
family of SR proteins. Although not part of the core spliceosome, SRSF1 plays a crucial 
role in pre-mRNA splicing (Sapra et al., 2009). Additionally, SRSF1 prevents R-loop 
formation and the resulting DNA damage, possibly by preventing the annealing of the 
nascent RNA with the template DNA (Li and Manley, 2005). We therefore investigated 
whether the lack of SRSF1 phosphorylation might be responsible for the genomic 
instability observed in SRPK2-depleted cells. To test this hypothesis, we ectopically 
expressed  wild-type SRSF1 (SRSF1-WT) or a mutant version of SRSF1 (SRSF1-PhosM) 
with serine-to-aspartate substitutions that mimic the phosphorylated protein in SRPK1- and 
SRPK2-depleted cells (Cazalla et al., 2002; Misteli et al., 1998). Both SRSF1-WT and 
SRSF1-PhosM exhibited a typical speckles-like pattern similar to the endogenous SRSF1 
(Fig.15a). However, contrary to our hypothesis, ectopic expression of each SRSF1 
proteins failed to rescue the DNA damage phenotype of SRPK2-depleted cells (Fig.15b). 
These data suggest that lack of SRSF1 phosphorylation is not the cause of the genomic 
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3.2 DEAD box helicases 
The failure of SRSF1 to resolve DNA damage in SRPK2-depleted cells instigated us to 
look for alternative SRPK2 specific substrates. Our search revealed DDX23, a specific 
SRPK2 substrate that is not phosphorylated by SRPK1 (Mathew et al., 2008). DDX23 is a 
RNA helicase that belongs to the DEAD box class.  
RNA helicases lie at the heart of RNA processing from transcription to translation and 
decay. They are present in different cellular compartments (like cytosol, mitochondria, and 
nucleus) because of their diverse functions in different steps of RNA maturation. Among 
the different helicase families, DEAD box proteins form the largest group. As the name 
Figure 15. SRSF1 is not sufficient to rescue DNA damage in SRPK2 depleted cells. a) 
Immunofluorescence analysis of SRSF1-WT and SRSF1-PhosM in U-2OS cells. Scale bar: 10 μm. 
b) Immunoblots showing γH2AX, SRSF1 SRPK1 and SRPK2 levels in SRPK1 and SRPK2 RNAi-
depleted U-2OS cells that were transiently transfected with: SRSF1-WT or SRSF1-PhosM. Histone 
H2A and α-tubulin served as loading controls. Data are representative of three independent 
experiments. 
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suggests, they have a conserved DEAD box motif that has aspartate(D)-glutamate(E)-
alanine(A)-aspartate(D) aminoacids (Jankowsky, 2011; Jarmoskaite and Russell, 2014). 
They orchestrate the functions of super molecular machines like the spliceosome by 
structurally remodeling RNA and protein complexes (Will and Lührmann, 2011). 
Mutations in DEAD box proteins have been attributed to a wide variety of diseases, 
including cancer (Yin et al., 2015).  
 
3.2.1 Structure of DEAD box helicases 
 
A typical DEAD box protein contains 12 highly conserved sequence motifs. The ‘DEAD 
box’ is part of the motif II (Fig.16a).  These evolutionary conserved enzymes use energy 
from ATP to remodel RNA and RNPs. ATP and RNA binding sites reside between the two 
helicase domains on either side. The two helicase domains form a closed cleft, to 
productively bind and hydrolyse ATP. Multiple amino acids are responsible for 
interactions with ATP and RNA independently, making it difficult to inactivate DEAD box 
proteins (Fig.16b) (Rocak and Linder, 2004). DEAD box proteins bind to the sugar 
phosphate backbone of RNA (~5 nucleotides), bending the RNA in a conformation 
characteristic only to DEAD box group of helicases. The helicase domain attains a more 
orderly conformation in the presence of either RNA or ATP. However, it is still unclear 
how the RNA and ATP binding sites signal each other (Linder and Jankowsky, 2011). 
Regulatory elements reside in either N-terminal and/or C-terminal domains that flank the 
helicase domain. Most of the data on DEAD box proteins arise from peptides that form the 
helicase domain, giving very little information on these regulatory elements. For instance, 
human DDX23 (unlike yeast Prp28), retains a RS-domain in its N-terminal regulatory 
domain that is specifically phosphorylated by SRPK2  (Mathew et al., 2008; Muhlmann et 
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3.2.2 Mechanism of action of DEAD box helicases 
One of the major differences between DEAD box helicases and other DNA/RNA helicases 
is the lack of unwinding polarity. The lack of unwinding polarity allows the DEAD box 
helicase to unwind RNA/DNA in any direction (5’→3’ or 3’→5’) (Jankowsky, 2011)   
DEAD box helicases can also load onto RNA at any of its extremities and in a manner that 
depends on the RNA secondary structure (e.g., CYT19 from Neurospora crassa and 
bacterial DbpA) (Tijerina et al., 2006). DEAD box helicases catalyze both ATP-dependent 
and independent functions that promote complex RNA rearrangements (Linder and 
Jankowsky, 2011). For example, nucleolar DDX21 displays intrinsic ATP-independent 
activity (Calo et al., 2014). The RNA remodeling/helicase activity discrepancies exhibited 
by DEAD box proteins in an in vitro or in vivo setting suggest the requirement of co-
factors and/or other cell signaling pathways for their activity. For example, DEAD box 
Figure 16. Schematic view of DEAD box helicases. a) Canonical DEAD box helicase with 
conserved sequence motifs (Q, I, Ia, Ib, Ic, II, III, IV, Iva, V, Va, VI). b) Structure of the helicase 
core domains of the DEAD box protein Vasa from D. melanogaster. Note the ATP and RNA 
binding sites on either side of helicase core. 
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proteins like Ded1 and Mss116 can act as ‘strand annealers’ independently of ATP 
(Jarmoskaite and Russell, 2014; Linder and Jankowsky, 2011). Once bound to RNA, 
DEAD box helicases start strand separation taking the energy from ATP hydrolysis. The 
unwinding rate constant is indirectly proportional to length and stability of duplex and 
presence of ADP. Depending on the processivity and ATP hydrolysis, the helicase reaction 
can be productive (resulting in the unwinding of duplex) or futile (re-annealing of duplex 
after the helicase dissociation) (Jankowsky, 2011; Linder and Jankowsky, 2011). 
 
3.2.3 DDX23 
Although small nuclear RNA (snRNA) forms the catalytic core of the spliceosome, various 
accessory proteins lie at the basis of the dynamic molecular rearrangements that dictate 
pre-mRNA splicing. From early to late splicing factors, there is a dynamic interplay 
between different splicing factors and DExD/H box helicases (DEAD box, DEAH and the 
SKI families of proteins are all referred to as DExD/H box proteins) play central role in 
such molecular rearrangements (Wahl et al., 2009). DDX23 (also termed hPrp28/U5-
100K, yeast Prp28) and SNRNP200 (yeast Brr2) are involved in the transitions from a pre-
catalytic spliceosome to an activated spliceosome. Studies in yeast, revealed that Prp28 
drives the displacement of the U1 snRNP from the 5’ splice site and proof-reads the splice 
sites (Fig.17a). Further, mutagenesis studies demonstrated the requirement of both the 
Prp28 ATPase and helicase activities for pre-mRNA splicing (Chang et al., 1997). 
However, ATPase-independent Prp28 activity was also reported to occur during splicing 
(Price et al., 2014). This variety of functions suggests that a complex molecular network 
regulates Prp28 activity, through mechanisms that might involve post-translational 
modifications such as phosphorylation. In human cells, DDX23 which is a part of 
U5snRNP complex contains around 230 N-terminal residues that are rich in 
arginine/serine, arginine/glutamate and arginine/aspartate dipeptide motifs and therefore 
have been annotated as an RS-like domain (Fig. 17b) (Teigelkamp et al., 1997). The 
DDX23 RS domain is phosphorylated specifically by SRPK2 (Mathew et al., 2008; Wahl 
et al., 2009). This phosphorylation drives a dynamic switch required for the association of 
DDX23 with the U4/U6.U5 tri-snRNP (Mathew et al., 2008; Xiang et al., 2013). In 
agreement, SRPK2 knockdown results in hypophosphorylation of DDX23 and destabilizes 
its association with the U5 snRNP (Boesler et al., 2016; Mathew et al., 2008). 
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Figure 17. Role of DDX23 in pre-mRNA splicing. a) The stepwise interaction of the core-spliceosomal 
proteins (colored circles) in the removal of an intron (red line) from a pre-mRNA containing two exons (gray 
boxes). Transition from complex A to complex B has been shown here, where splicing reaction starts with 
binding of U1 snRNP to 5’ splice site and U2 snRNP to 3’splice site. The tri-snRNP compex (U4/U6.U5 
snRNPs) consisting of active phosphorylated DDX23 (dark gray) aligns on complex A to form complex B 
with the displacement of U1 snRNP from 5’ splice site. Yeast Prp28 acts at a later stage during spliceosome 
activation (the B complex to B* complex transition). b) Disordered domain (1–257, green), DEAD box 
domain (410–642, orange), and HELICc domain (678–759, red) of DDX23 with RS domain (1–138). Note 




DDX23 suppresses RNA-mediated genome instability 
 
               Chapter 3. 61 
 
Figure 18. A phosphomimetic version of DDX23 rescues the genome integrity in SRPK2-
depleted cells. a) Immunofluorescence analysis of DDX23-WT, DDX23-PhosM, and DDX23-
PhosIA in U-2OS cells. Scale bar: 10 μm. b)  Immunoblots showing γH2AX, DDX23, SRPK1 and 
SRPK2 levels in SRPK1 and SRPK2 RNAi-depleted U-2OS cells that were transiently transfected 
with DDX23-WT or DDX23-PhosM. c) Immunoblots showing γH2AX, SRPK2 and DDX23 in U-
2OS cells following RNAi-depletion of SRPK2 and transient transfection of DDX23-WT or DDX23-
PhosIA as detailed in the figure. Molecular weight markers (KDa) are shown on the left. α-tubulin 
and histone H2A levels served as loading controls. Data are representative of three independent 
experiments. 
 
3.3  A phosphomimetic DDX23 rescues the genome integrity in SRPK2-
depleted cells 
To address the role of DDX23 in the SRPK2-associated genomic instability phenotype, we 
made two constructs of DDX23: 1) a wild type DDX23 (DDX23-WT) and 2) a 
phosphomimetic version of DDX23 (DDX23-PhosM). To make DDX23-PhosM, we 
replaced 9 serine residues in the RS domain with 9 aspartates. The choice of the serines 
that were mutated was made based on previously reported data (Teigelkamp et al., 1997). 
Both the DDX23-WT and DDX23-PhosM were tagged with GFP. Analysis of their sub-
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cellular localization upon overexpression in U2-OS cells revealed a nuclear speckles-like 
pattern typical of other RNA-processing proteins (Fig.18a). We then ectopically expressed 
both DDX23 proteins in SRPK1 or SRPK2-depleted cells to assess their effect on the DNA 
damage (evaluated by measuring γH2AX levels). As expected, knockdown of SRPK2 but 
not SRPK1 induced γH2AX (Fig.18b). Notably, ectopic expression of DDX23-PhosM, but 
not of DDX23-WT, was able to completely abolish the DNA damage induced by the 
SRPK2 knockdown (Fig.18b). We then made a third version of DDX23 where the same 9 
serine residues of the RS domain were mutated to 9 alanines. Mutation of serine to alanine 
blocks DDX23 phosphorylation rendering the protein phospho-inactive (DDX23-PhosIA). 
This protein also localized to nuclear speckles and was also detected in nucleoli (Fig.18a). 
Notably, ectopic expression of DDX23-PhosIA failed to reduce γH2AX levels in SRPK2-
depleted cells (Fig.18c). These data suggest that DDX23 phosphorylation is necessary and 
sufficient to rescue the genome integrity in SRPK2-depleted cells.    
We then asked if the helicase domain of DDX23 is required to suppress the DNA damage 
in SRPK2-depleted cells. To this end, we constructed a truncated version of DDX23-
PhosM, which we named DDX23-PhosM-ΔHel. This protein lacks most of the helicase 
domain while maintaining the serine-to-aspartate substitutions of the phosphomimetic 
version of DDX23. Again, we could detect DDX23-PhosM-ΔHel in nuclear speckles and 
associated with chromatin (Fig.19a,b). We then overexpressed the three versions of 
DDX23 (WT, PhosM and PhosM-ΔHel) in control and SRPK2 RNAi U2-OS cells. In 
agreement with our previous results, DDX23-PhosM but not DDX23-WT was able to 
completely rescue the γH2AX levels upon SRPK2 depletion. Notably, the phosphomimetic 
DDX23 lacking the helicase domain (DDX23-PhosM-ΔHel) failed to reduce the DNA 
damage phenotype of SRPK2-depleted cells as demonstrated by western blot and 
immunofluorescence (Fig.19c,d). Altogether, these data show that phosphorylation of 
DDX23 and its helicase activity are absolutely necessary to counteract the DNA damage 
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We next sought to investigate if the role of DDX23 in suppressing R-loops requires a 
functional U5 snRNP. To this end, we performed RNAi against PRP8, a U5 snRNP 
scaffolding protein PRP8, which is at the core of U5 snRNP assembly and plays key roles 
during the catalytic activation of the spliceosome (Agafonov et al., 2016; Grainger and 
Beggs, 2005; Ritchie et al., 2008). Depletion of PRP8, did not induce any DNA damage 
(Fig.20a) and did not affect the ability of DDX23-PhosM to suppress DNA damage in 
SRPK2-depleted cells (Fig.20b-d). Similar data were obtained upon depletion of PRP6, 
Figure 19. Helicase activity of DDX23 is necessary to regulate RNA-mediated genome 
instability. a) Immunofluorescence analysis of DDX23-PhosM-ΔHel in U-2OS cells. Scale bar: 
10 μm. b) Co-Immunoprecipitation of wild type (WT) and helicase-dead DDX23 mutants 
(PhosM-ΔHel) with histone H2A in U-2OS cells. DDX23-purified complexes were resolved by 
SDS-PAGE and blotted with antibodies against GFP (to detect DDX23) or histone H2A. The 
Input lane represents total cell lysates and IgG IP denotes the negative control 
immunoprecipitation obtained with an isotype-matched antibody. The asterisks indicate the 
bands corresponding to GFP-tagged DDX23 proteins. Molecular weight markers (KDa) are 
shown on the left. c) γH2AX, DDX23 and SRPK2 levels in SRPK2 RNAi-depleted U-2OS cells 
that were transiently transfected with DDX23-WT, DDX23-PhosM or DDX23-PhosM-ΔHel. 
Histone H2A and α-tubulin served as loading controls. Molecular weight markers (KDa) are 
shown on the left. Data are representative of three independent experiments. d) γH2AX foci and 
DDX23-GFP in control and SRPK2 RNAi-depleted U-2OS cells upon transient transfection 
with either DDX23-WT, DDX23-PhosM or DDX23-PhosM-ΔHel. Means and standard 
deviations of the percentage of cells with ≥ 10 γH2AX foci are plotted on the right-hand side. 
Data are from a minimum of 100 cells scored in three independent experiments. Scale bar: 10 





DDX23 suppresses RNA-mediated genome instability 
 
               Chapter 3. 64 
 
Figure 20. PRP8 is not necessary for the suppression of DNA damage by DDX23. a) γH2AX 
and PRP8 levels in PRP8 RNAi-depleted U-2OS cells. b)  γH2AX, SRPK2 and PRP8 levels in U-
2OS cells following RNAi-depletion of SRPK2 and PRP8 and transiently transfected with DDX23-
WT or DDX23-PhosM, as detailed in the figure. Molecular weight markers (KDa) are shown on the 
left. α-tubulin and histone H2A levels served as loading controls. Data are representative of three 
independent experiments. c) and d) γH2AX foci and DDX23 staining in control, PRP8, SRPK2 
RNAi depleted U-2OS cells upon transient transfection with DDX23-WT, DDX23-PhosM. Means 
and standard deviations of the percentage of cells with 10 or more γH2AX foci are plotted. Data are 
from a minimum of 100 cells scored in three independent experiments. Scale bars: 10µm. Satistical 
significance was determined using two-tailed Student’s t-test. *p<0.05  
 
another U5 snRNP component that is necessary for spliceosome activity (Makarov et al., 
2000) (Fig.21). Altogether, these results show that phosphorylation of DDX23 restores the 
genome stability in SRPK2-deficient cells through a process that does not require a 
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3.4 Loss of DDX23 drives R-loop-dependent genome instability 
To further explore the role of DDX23 in maintaining genome stability, we measured 
cellular R-loop levels upon transient DDX23 knockdown. DDX23 was depleted using an 
independent pool of siRNA. A control RNAi included a pool of siRNA directed against 
firefly luciferase gene. In agreement with a role in R-loop associated genome stability, 
transient depletion of DDX23 resulted in a strong accumulation of nuclear R-loops 
(Fig.22a). Notably, there was also a prominent increase in total γH2AX levels as assessed 
by immunoblots of protein lysates collected from control and DDX23 RNAi treated cells 
(Fig.22b). Strikingly, ectopic expression of RNase H1 reduced nuclear γH2AX foci 
Figure 21. PRP6 is not necessary for the suppression of DNA damage by DDX23. a) γH2AX in 
PRP6 RNAi-depleted U-2OS cells. Molecular weight markers (KDa) are shown on the left. α-
tubulin levels served as loading controls. Data are representative of three independent experiments.. 
b) PRP6 mRNA levels in control and PRP6 RNAi treated U2-OS cells as assessed by primers 
against exon 9 and 6 of human PRP6 locus. Data was normalized against values obtained in control 
(i.e. without PRP6 knockdown) cells. Means and standard deviations are from a minimum of three 
independent qPCR experiments. Statistical significance was determined using two-tailed Student’s t-
test. **p<0.005, ***p<0.0005  c) and d) γH2AX foci and DDX23 staining in control, PRP8, SRPK2 
RNAi depleted U-2OS cells upon transient transfection with DDX23-WT, DDX23-PhosM. Means 
and standard deviations of the percentage of cells with 10 or more γH2AX foci are plotted. Data are 
from a minimum of 100 cells scored in three independent experiments. Scale bars: 10µm. Statistical 
significance was determined using two-tailed Student’s t-test. **p<0.005, ***p<0.0005  
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observed upon depletion of DDX23, suggesting that R-loops are the major source of the 
DNA damage observed in DDX23 deficient cells (Fig.22c).  
Figure 22. Loss of DDX23 drives RNA-dependent genomic instability. a) Immunofluorescence 
analysis of R-loops obtained with the S9.6 antibody in control and DDX23-depleted U-2OS cells. 
The nucleoplasmic intensity of the S9.6 staining is plotted on the right-hand side. At least 100 cells 
from three independent experiments were scored. Statistical significance was determined using 
Mann-whitney test. ***p<0.0005 Scale bar: 10µm. b) Immunoblots showing γH2AX and DDX23 
levels in control and DDX23-depleted U-2OS cells. Histone H2A and α-tubulin served as loading 
controls. Molecular weight markers (KDa) are shown on the left. Data are representative of three 
independent experiments. c) γH2AX foci in control and DDX23-depleted U-2OS cells transiently 
transfected with an RNase H1-GFP expression plasmid. Means and standard deviations of the 
percentage of cells with ≥10 γH2AX foci are plotted on the right-hand side. Data are from a 
minimum of 100 cells scored in three independent experiments. Scale bar: 10 μm. All statistical 
significance was determined using two-tailed Student’s t-test. *p<0.05 
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We also observed phosphorylation of p53-binding protein 1 (53BP1) and Replication 
protein A (RPA) proteins (which are molecules involved in the repair of DNA DSBs) upon 
depletion of DDX23 and SRPK2 (Fig.23a). Additionally, in order to inspect the direct 
effect of SRPK2 and DDX23 on genome instability we also scored the number of DSB-
associated chromosome aberrations (like single- and double- chromatid breaks). For this 
purpose, we collected metaphase chromosomes from cells depleted of SRPK2 and DDX23. 
We observed that both SRPK2 and DDX23-depleted cells accumulate more DSB-
associated chromosomal aberrations than control cells exhibiting a strong genome instable 
phenotype (Fig. 23b). Altogether, these data disclose an important new role of DDX23 in 
preventing R-loop-dependent genome instability.  
In agreement with the view that phosphorylation of DDX23 by SRPK2 constitutes a new 
genome caretaker mechanism to ward-off against tumorigenic processes such as genomic 
instability, our pan-cancer data analysis revealed that 45% (24 out of 53) of all DDX23 
point mutations found in cancer samples are significantly enriched in the RS domain 
(Fisher’s Exact Test p-value < 0.05, Fig. 23c).  Moreover, 83% of these mutations are 
predicted to be potentially deleterious variants (Extended Data Table 2). Within this 
domain, 63% of the mutations affected either an arginine (R) or a serine (S) residue linking 
to the fact that SRPK preferentially phosphorylate serines than threonine close to arginine 
residues (Ghosh and Adams, 2011). Additionally, DDX23 copy-number alterations were 
observed in several cancers, such as adenoid cystic carcinoma (ACC). Our analyses 
detected homozygous deletions of the DDX23 locus in 17% (10 out of 60) ACC samples 
(Fig. 23d). ACC from the salivary glands is characterized by perineural invasion and high 
rates of metastasis to distant organs like lungs, liver and bone (Spiro, 1997). Chromosomal 
translocations leading to formation of the MYB-NFIB gene fusion is a recurrent molecular 
feature of ACC. However, there is no successful chemotherapy available to treat ACC. 
Indeed, treatment of ACC is confined to surgery and radiation, while chemotherapy has 
been of limited palliative benefit in patients with advanced disease (Chae et al., 2015; 
Spiro, 1997). Therefore, the marked genomic instability that follows deletion of DDX23 
may explain the recurrent high-level losses in 12q13−the genomic housing of 
DDX23−previously observed in ACC (Ho et al., 2013). 
 
DDX23 suppresses RNA-mediated genome instability 
 
               Chapter 3. 68 
 
In a nutshell, 
1) Phosphorylation of DDX23 is necessary and sufficient to restore the DNA 
damage in SRPK2-deficient cells through a process that requires its helicase 
activity. 
2) SRPK2-DDX23 is a novel signaling axis employed by cells to suppress RNA-
mediated genome instability. 
3) R-loops are the major source of DNA damage in DDX23-deficient cells. 
4) Dysfunction of DDX23 can explain genome instability observed in ACC. 
 
 
Figure 23. DDX23 depleted cells exhibit severe genome instability phenotype. a) Immunoblots 
showing phosphorylated 53BP1 (p53BP1), phosphorylated RPA (pRPA), SRPK2 and DDX23 levels 
in SRPK2 and DDX23 RNAi-depleted HeLa cells. α-tubulin served as a loading control. Molecular 
weight markers (KDa) are shown on the left. Data are representative of three independent 
experiments. b) Typical metaphase spread of HeLa cells treated with siRNA against SRPK2 and 
DDX23 showing two different sub-populations characterized as normal-like and metaphase with ≥3 
aberrations. Red arrows point to chromosomal aberrations. Percentage of metaphases with ≥3 
chromosome aberrations was scored from three independent experiments with mean and standard 
deviations were shown on right side. At least 80 spreads were scored per condition. Scale bar: 10 
μm. Statistical significance was determined using two-tailed Student’s t-test. **p<0.005, *p<0.05. c) 
Schematic representation of the point-mutations found in the DDX23 locus in the cancers 
represented in the cBioPortal (117 studies with mutation data). The RS, DEAD and helicase domains 
of DDX23 are shown. d) Frequency of copynumber alterations (CNA) of the DDX23 locus in ACC 
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Highlights 
 DDX23 nucleates at R-loops-containing loci. 
 R-loops cause RNA Pol II pausing. 
 Paused RNA Pol II acts as an R-loop ‘sensor-signal’. 
 
4.1 DDX23 accumulates at R-loop-containing chromatin loci  
As DDX23 is necessary to maintain cellular R-loop levels, we asked if this helicase is 
recruited to R-loops-forming loci. To test this, we induced the formation of R-loops by 
depleting THOC1, a component of the THO/TREX complex that, if depleted, leads to 
aberrant accumulation of R-loops (Bhatia et al., 2014; Domínguez-Sánchez et al., 2011). 
First, we transiently depleted THOC1 and DDX23 using pooled siRNAs and assessed the 
level of endogenous R-loops at APOE and ACTB loci (Fig.24a). It was previously shown 
that THOC1 depletion induces R-loop levels at these loci (Bhatia et al., 2014; Skourti-
Stathaki et al., 2011) . We then used the S9.6 antibody to isolate R-loops by performing 
DNA-RNA immunoprecipitation (DRIP). As expected, in the absence of THOC1, we 
observed a significant increase in R-loop levels in APOE and ACTB but not in SNRPN 
(already described to lack R-loops even after THOC1 depletion (Bhatia et al., 2014; Sanz 
et al., 2016) (Fig.24b). In agreement with the role of R-loops in inducing DNA damage, 
we also observed a significant increase in γH2AX levels in APOE and ACTB loci in an R-
loop dependent manner as assessed by γH2AX ChIP (Fig.24c). Furthermore, in agreement 
with a role in the suppression of R-loops, DDX23 knockdown also resulted in a prominent 
accumulation of these structures in APOE and ACTB (Fig. 24b).  
We then explored if DDX23 is recruited to the chromatin regions where R-loops form 
upon THOC1 knockdown. In fact, ChIP experiments showed a robust accumulation of 
DDX23 in R-loop-containing APOE and ACTB loci, but not in the R-loop-free SNRPN 
locus (Fig.25a). Importantly, suppression of R-loops by overexpression of RNase H1 
significantly reduced the recruitment of DDX23 to APOE and ACTB loci in THOC1-
depleted cells (Fig.25a). In contrast, this recruitment was not affected by SRPK2 depletion 
(Fig.25b), suggesting that DDX23 phosphorylation is required for the protein activity 
(namely to resolve co-transcriptional R-loops) but not to its chromatin binding. These 
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Figure 24. THOC1 and DDX23 depleted cells accumulate R-loops at gene loci . a) Immunoblots 
of THOC1, DDX23 and γH2AX in U2-OS cells depleted of THOC1 and DDX23. α-tubulin and 
H2A served as loading controls. Molecular weight markers (KDa) are shown on the left. Data are 
representative of three independent experiments. b) DNA-RNA immunoprecipitations (DRIP) in 
DDX23 and THOC1 RNAi-depleted cells is shown in the right-hand side. Data are presented as fold 
increase over the input sample. Means and standard deviations from three independent DRIP 
experiments are plotted. Statistical significance was determined using two-tailed Student’s t-test. *p 
< 0.05 **p<0.005. c) ChIP analysis of γH2AX in THOC1 RNAi-depleted cells with (+ RNase H1) or 
without transient transfection of RNase H1. Data was normalized against the ChIP values obtained 
in SNRPN negative locus. Means and standard deviations are from a minimum of three independent 
experiments. *p<0.05, **p<0.005, ***p<0.0005 (two-tailed Student’s t-test).    
 
Figure 25. DDX23 nucleates at R-loop-containing sites. a) ChIP analysis of DDX23 in THOC1 
RNAi-depleted cells with (+ RNase H1-GFP) or without transient transfection of RNase H1. Data 
was normalized against the ChIP values obtained in control cells (i.e. without THOC1 knockdown). 
Means and standard deviations from three independent DRIP experiments are plotted. Statistical 
significance was determined using two-tailed Student’s t-test. *p < 0.05 **p<0.005. b) ChIP analysis 
of DDX23 in SRPK2 RNAi-depleted U-2OS cells. Data are shown as fold enrichment over the ChIP 
values obtained in control cells. Means and standard deviations are from a minimum of three 
independent ChIP experiments.  
results reveal that DDX23 accumulates at chromatin regions containing R-loops and is 
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Figure 26. RNA Pol II pauses at R-loop-containing sites. ChIP analysis of RNA Pol II (a) and Ser5p 
RNA Pol II (b) in THOC1 RNAi-depleted cells with (+ RNase H1) or without transient transfection of 
RNase H1. Data was normalized against the ChIP values obtained in control cells (i.e. without THOC1 
knockdown). Means and standard deviations from three independent ChIP experiments are plotted. 
Statistical significance was determined using two-tailed Student’s t-test. *p < 0.05 **p<0.005. c) Total 
mRNA levels of ACTB, APOE and SNRPN in U-2OS cells treated with control and THOC1 RNAi. Data 
are relative to the U6 snRNA expression and was normalized against the RT-qPCR values obtained in 
control cells. Means and standard deviations are from a minimum of three independent experiments.  
4.2 RNA Pol II pausing nucleates SRPK2 and DDX23 at R-loop-
containing loci 
Co-transcriptional R-loops impact on RNA Pol II transcription dynamics. For instance, 
they are involved in the promoter-proximal pausing and promote efficient transcription 
termination by slowing down RNA Pol II, therefore facilitating the timely recruitment of 
RNA processing factors (Ginno et al., 2012; Skourti-Stathaki et al., 2011 Harlen et al., 
2016; Nojima et al., 2015). For this reason, we sought to investigate whether oscillations in 
transcription reach back to ‘signal’ the suppression of persistent R-loops.  
In order to investigate RNA Pol II dynamics at the site of R-loop formation, we induced R-
loops in cells by depleting THOC1. In agreement with the view that R-loops slow down 
transcription, we detected a significant accumulation of RNA Pol II in APOE and ACTB 
loci where R-loops had been detected, but not in the SNRPN locus, upon THOC1 
knockdown (Fig.26a). THOC1 knockdown did not cause significant changes in the 
expression levels of APOE and ACTB (Fig.26c), suggesting that the observed RNA Pol II 
accumulation is not the result of changes in the transcription rate, but rather a localized 
pausing event. Indeed, the RNA Pol II accumulated at the APOE and ACTB loci carried a 
serine 5-phosphorylation (Ser5P) pattern (Fig.26b), which is suggestive of paused 
transcription complexes (Buratowski, 2009). Notably, the stalled RNA Pol II complexes 
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Figure 27. RNA Pol II pausing nucleates SRPK2 at R-loop-containing sites. a) Nuclear 
immunoprecipitations of RNA Pol II on control and THOC1 RNAi depleted U-2OS cells. Purified 
complexes were resolved by SDS-PAGE and blotted with antibodies against Ser5P-RNA Pol II, 
SRPK1 or SRPK2. The Input lane represents total cell lysates and IgG IP denotes the negative 
control immunoprecipitation. Molecular weight markers (KDa) are shown on the left. Data are 
representative of three independent experiments. b) Individual profiles with 20 bp windows of RNA 
Pol II and SRPK2 distribution (RPKMs) along four different loci. c) ChIP analysis of SRPK2 in U-
2OS cells. Data were normalized against the input values. Means and standard deviations are from a 
minimum of three independent ChIP experiments. 
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Given the intimate link with R-loops, we reasoned that stalled RNA Pol II complexes 
would constitute ideal molecular sensors to ‘signal’ the location of intragenic R-loops and 
initiate a molecular pathway towards their suppression. According to our model, paused 
RNA Pol II would nucleate SRPK2-dependent phosphorylation of DDX23. In agreement 
with our view, co-immunoprecipitation experiments revealed that the accumulation of R-
loops upon THOC1 knockdown increased Ser5P RNA Pol II levels and promoted the 
interaction of RNA Pol II with SRPK2, but not with SRPK1 (Fig.27a). Moreover, the 
analysis of ChIP-seq data revealed that SRPK2 is enriched at sites of RNA Pol II pausing 
(Fig.27b). Finally, we observed that SRPK2 coincides with DDX23 at APOE and ACTB 
loci (Fig.27c). Altogether, these data strengthen our proposed model whereby changes in 
transcription dynamics initiate a molecular pathway leading to SRPK2-dependent 





























Imagination meets memory in dark. 
Annie Dillard 
 
Discussion primes ideas, argument primes conflicts. 
Anonymous 
 
Every great magic trick consists of three parts or acts. The first part is called "The Pledge". The magician 
shows you something ordinary: a deck of cards, a bird or a man. He shows you this object. Perhaps he asks 
you to inspect it to see if it is indeed real, unaltered, normal. But of course... it probably isn't. The second act is 
called "The Turn". The magician takes the ordinary something and makes it do something extraordinary. Now 
you're looking for the secret... but you won't find it, because of course you're not really looking. You don't 
really want to know. You want to be fooled. But you wouldn't clap yet. Because making something disappear 
isn't enough; you have to bring it back. That's why every magic trick has a third act, the hardest part, the part 
we call "The Prestige". 
Opening scene from ‘The Prestige’- Chris Nolan 
 
Atticus told me to delete the adjectives and I'd have the facts. 
Harper Lee 
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Highlights 
 RNA Pol II ‘senses and signals’ R-loops and nucleates SRPK2 as the ‘signal 
transducer’ that will phosphorylate DDX23 − ‘the effector’ − to maintain R-loop 
homeostasis. 
 The genomic instability resulting from DDX23 deficiency may explain the frequent 
high-level losses in 12q13 − the genomic housing of DDX23 – observed in ACC of 
the salivary glands.   
 
5.1 SRPK2 and DDX23 – new players that prevent RNA-mediated 
genome instability 
SRPK1 and SRPK2 can be categorized as ‘stress response’ kinases whose localization, 
activity and functional outcome changes based on different stress signals (Zhong et al., 
2009). Available data strongly suggest their role in changing alternative splicing decisions 
by phosphorylating different SR proteins (Twyffels et al., 2011). Although there is an 
overlap between the substrates of SRPK1 and SRPK2, they seem to have different 
functional outcomes (Varjosalo et al., 2013). Indeed it is surprising that only SRPK2 plays 
a crucial role in genome instability, as described in this thesis. This intriguing result is 
followed by the fact that SRSF1 phosphomimic was not able to rescue the DNA damage 
phenotype suggesting the functioning of a new SRPK-SR protein phosphorylation switch.  
Additional post-translational modifications could even add to the complexity of SRPK2 
function. For instance, histone acetyltransferase Tip60 acetylates the RNA recognition 
motif of SR splicing factor 2 (SRSF2) and interferes with SRSF2 phosphorylation by 
inhibiting the nuclear translocation of SRPK2 (Edmond et al., 2011). This 
acetylation/phosphorylation balance controls the activity of SRSF2. Tip60 was recently 
shown to bind to R-loop-containing loci in mouse embryonic stem cells (Chen et al., 
2015). In agreement, depletion of R-loops decreased the binding of Tip60 to chromatin  
and increased the polycomb repressive complex 2 occupancy genome wide impairing stem 
cell differentiation (Chen et al., 2015). Interestingly, the gene encoding Tip60 is a tumor 
suppressor and is frequently mutated in head and neck squamous cell carcinoma, breast 
carcinoma and lymphomas (Gorrini et al., 2007). Whether Tip60 and SRPK2 orchestrate 
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the acetylation/phosphorylation switch in addtional SR proteins (namely DDX23) to 
regulate R-loop levels in order to prevent cancer development is yet to be investigated.   
We also observed different patterns of intra-nuclear distribution of SRPK1 and SRPK2. 
Although both kinases exhibit typical speckles-like pattern commonly exhibited by 
splicing proteins, SRPK2 has a stronger nucleolar signal. Strikingly, R-loops tend to form 
or to persist longer in nucleoli as a result of ribosomal DNA transcription by RNA 
polymerase I (El Hage et al., 2010). Additionally, we also observed a robust increase in 
nucleolar R-loops in cells depleted of SRPK2. This opens up a new question on what is the 
role of SRPK2 in RNA Pol I transcription, if any? However, considering the fact that 
triptolide (specific inhibitor RNA Pol II) was able to reduce DNA damage levels 
significantly in SRPK2 RNAi treated cells we can speculate that SRPK2 has a more 
prominent role in preventing RNA Pol II-derived-R-loops. Interestingly, RNA Pol II 
transcripts originating from intronic Alu elements (aluRNAs) are enriched in the nucleolus 
and associate with nucleolar proteins. Inhibiting RNA Pol II transcription disrupts the 
association of aluRNAs with nucleoli and severely challenges nucleolar organization 
(Caudron-Herger et al., 2015). aluRNAs escape degradation after pre-mRNA splicing and 
processing and remain stable as small RNPs (Jády et al., 2012). Therefore, it will be 
interesting to see if non-coding RNA species (in this case aluRNAs) generated by RNA Pol 
II form R-loops in nucleolar regions and SRPK2 plays any role in regulating such trans-R-
loops. 
Cells have evolved molecular mechanisms that can suppress R-loops, such as the novel 
SRPK2-DDX23 signaling axis described in this thesis. DDX23 is part of a family of R-
loop suppressors that includes other helicases, such as SETX, AQR, DHX9 and PIF1. 
However, how exactly these helicases work at the molecular level is still not clearly 
known. How do DDX23 and other helicases distinguish dsDNA, dsRNA and RNA-DNA 
hybrids? We did observe that the helicase activity of DDX23 is essential for its R-loop 
suppressing function. Strikingly, the purified yeast orthologue of DDX23, Prp28, has no 
detectable ATPase or helicase activity in vitro (Muhlmann et al., 2014), even though both 
activities are required for splicing in vivo (Chang et al., 1997).This suggests the need of 
accessory factors that work together with DDX23 activating it. An example of that is 
herein illustrated by the role of the SRPK2-dependent phosphorylation of DDX23, which 
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is required for its integration in the tri-snRNP complex and proficient splicing mechanism 
(Mathew et al., 2008). 
 
5.2 Potential link between DDX23 and adenoid cystic carcinoma  
The finding that DDX23-depleted cells exhibit a marked genome instability phenotype 
strongly suggests a role in cancer. In agreement with this view we detected DDX23 
homozygous deletions in 10 out of 60 (17%) adenoid cystic carcinoma (ACC) samples. 
ACC is a rare form of malignant neoplasm that arises within secretory glands. The 
development of the disease is fairly slow yet it follows a steady relentless course. 
Perineural invasion and high rates of distant metastasis to organs like lungs, liver and bone 
are characteristic features (Fordice et al., 1999; Spiers et al., 1996). Like for other cancers, 
the ACC genome exhibit high levels of genome instability. Except for the MYB-NFIB gene 
fusion there are no ACC characteristic genetic abnormalities known so far.  
A recent cohort of 60 ACC samples (55 exome sequencing, 5 genome sequencing) 
with matched normal samples revealed that mutations are enriched in pathways involved 
in chromatin remodeling, DNA damage response, protein kinase A and phosphatidyl 
inositol 3-kinase signaling (Ho et al., 2013). Moreover recurrent and high-level losses were 
also identified in 6q24, 12q13 and 14q loci. Remarkably, 12q13 is the genomic location of 
DDX23, anticipating a link between ACC development and the R-loop-dependent genome 
instability.  
 
5.3 Role of R-loops in defining gene boundaries  
R-loops are widely distributed along the genome, with a tendency to localize at promoter 
and terminator regions of RNA Pol II transcribed genes (Skourti-Stathaki and Proudfoot, 
2014). R-loops at 3’ end of genes act to slowdown RNA Pol II favoring the recruitment of 
termination factors and an efficient transcription termination (Skourti-Stathaki et al., 
2011). Perturbation in such a mechanism might lead to termination defects resulting in 
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Recent work from our lab strongly suggests that, dysfunction of SET Domain 
Containing 2 (SETD2) leads to transcriptional read-through up to 4 Kb downstream 
termination sites (Grosso et al., 2015). SETD2 seeds three methyl groups on lysine 36 of 
histone 3 (H3K36me3) in RNA Pol II transcribed genes, a mark that is required for the 
recruitment of the histone chaperone complex FACT during transcription (Carvalho et al., 
2013). Notably, deficiency of FACT during transcription leads to R-loop-driven genome 
instability (Herrera-Moyano et al., 2014). Moreover, our group and others showed that loss 
of SETD2 increases DNA damage within transcriptional units (Aymard et al., 2014; Pfister 
et al., 2014). Interestingly, γH2AX and H3K36me3 co-exist in the same nucleosomes and 
help in the recruitment of DNA repair factors to DNA lesions located in transcriptional 
units (Carvalho et al., 2014). Altogether, these data suggest a model whereby H3K36me3 
deposited during transcription acts to prevent genome instability through a mechanism that 
may involve FACT-dependent suppression of R-loops. 
 
5.4 Stalled RNA Pol II − a sensor for R-loops 
Given that unscheduled R-loop formation compromises the genome stability, dedicated 
cellular mechanisms must be on call to react promptly in such cases (Sollier and Cimprich, 
2015). The work presented in this thesis, describes a mechanism involving RNA Pol II as 
the R-loop sensor, SRPK2 as the signal transducer and DDX23 as the molecular effector 
to ward off against deleterious intragenic R-loops. We detect DDX23 accumulation at 
chromatin loci where R-loops form, which are also co-occupied by Ser5P RNA Pol II and 
SRPK2. Given the association between Ser5P RNA Pol II and transcription pausing 
(Alexander et al., 2010; Nojima et al., 2015), we suggest that the concomitant 
accumulation of SRPK2 and DDX23 onto chromatin follows R-loop-dependent RNA Pol 
II pausing. While we cannot exclude that SRPK2 accumulates on transcription pause sites, 
at least partially due to their general role in phosphorylating mRNA processing factors (Ji 
et al., 2013; Lin et al., 2008; Pandit et al., 2013), its increased association with RNA Pol II 
observed in THOC1-depleted cells suggests a specific recruitment to chromatin in response 
to R-loops accumulation. We reason that the accumulation of Ser5P RNA Pol II – 
predominant near the transcription start site (Heidemann et al., 2013) – within the gene 
body challenges the expected phosphorylation pattern of elongating polymerases and 
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Figure 28. Proposed model for the role of SRPK2-DDX23 in the regulation of R-loops. RNA 
Pol II pausing (orange) recruits SRPK2 (purple) that phosphorylates DDX23 (gray) to prevent 
aberrant accumulation of R-loops and maintain the genome integrity. In the absence of either SRPK2 
or DDX23, the presence of R-loops favors DNA damaging events (e.g. through collisions with the 
replication machinery) that create genomic instability. 
 
signals the recruitment of both SRPK2 and DDX23. A similar mechanism linking Ser5P 
RNA Pol II and the recruitment of RNA-processing factors may explain the splicing-
dependent transcription pausing (Harlen et al., 2016; Nojima et al., 2015). “What are the 
differences, if any, between an R-loop-dependent and a splicing-dependent RNA Pol II 
pausing?” and “how does transcription pausing signal the nucleation of distinct molecular 
machineries?” are important questions that emerge from our model. Importantly, we 
should also consider the hypothesis that R-loops may form in response to the splicing-
dependent RNA Pol II pausing, as was recently shown in the case of transcription-blocking 
DNA lesions (Tresini et al., 2015). In this scenario, the SRPK2-DDX23 axis described 
here would be a good candidate to suppress such opportunistic R-loops. Further studies 
aimed at clarifying these open questions will certainly provide valuable insights into the 
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5.5 Concluding remarks 
The work presented in this thesis reveals that pausing of RNA Pol II initiates a signaling 
cascade whereby SRPK2 phosphorylates DDX23 culminating in the suppression of R-
loops. We show that in the absence of either SRPK2 or DDX23, accumulation of R-loops 
leads to massive genomic instability. Importantly, we detected homozygous deletions of 
the entire DDX23 locus in ACC. Our results unravel the molecular details of a novel link 
between transcription dynamics and RNA-mediated genomic instability that may play 
important roles in cancer development. Altogether, our data allow us to propose a model 
whereby R-loops trigger the RNA Pol II pausing, which in turn nucleates SRPK2-
dependent DDX23 phosphorylation (Fig.28). This model implies that DDX23 activation 
follows the accumulation of R-loops, placing this helicase as a suppressor rather than a 
preventer of R-loops. This separates it from the role of several other RNA processing 
factors, such as SRSF1 or THOC1 that prevent the formation of co-transcriptional RNA-
DNA hybrids. Instead, DDX23 would fall within the family of R-loop suppressors, on 
which the helicase SETX occupies a prominent position. Notably, while SETX resolves 
RNA-DNA hybrids to promote transcription termination (Skourti-Stathaki et al., 2011), we 
suggest that DDX23 acts to release RNA Pol II from R-loop-mediated pausing throughout 











To fight one might need to know  technique, but to hunt one need to use instincts. 
Anonymous 
 
What one fool can do another can do better! 
Feynman 
 
At some point, everything's gonna go south on you... everything's going to go south and you're going to say, 
this is it. This is how I end. Now you can either accept that, or you can get to work. That's all it is. You just 
begin. You do the math. You solve one problem... and you solve the next one... and then the next. And if you 
solve enough problems, you get to come home….  
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Cell culture 
U-2OS, HeLa and MCF7 cells were grown as monolayers in Dulbecco's modified Eagle medium-
DMEM (Invitrogen, Carlsbad, CA), supplemented with 10% (v/v) FBS, 1% (v/v) non-essential 
amino acids, 1% (v/v) L-glutamine and 100 U/ml penicillin-streptomycin. MCF10A cells were 
cultured in DMEM/F12 (Invitrogen, Carlsbad, CA) supplemented with 5% (v/v) horse serum, 
100µg/ml EGF, 1mg/ml Hydrocortisone, 1mg/ml cholera toxin, 10mg/ml insulin and 100U/ml 
penicillin-streptomycin (Debnath et al., 2003). All cells were maintained at 37°C in a humidified 
atmosphere with 5% CO2.  
 
RNA interference 
RNAi was achieved using synthetic siRNA duplexes. siRNAs targeting the firefly luciferase (GL2) 
were used as controls (Eurogentec, Seraing, Belgium). Cells were reverse transfected with 10 μM 
siRNAs using OptiMEM (Invitrogen) and Lipofectamine RNAiMAX (Invitrogen), according to the 
manufacturer's instructions. The sequence of the siRNAs is shown in Material and Methods 
Table 1. 
 
Plasmid construction and transfections 
DDX23 expression plasmids were obtained upon modification of pET21a(+)-DDX23 (kindly given 
by Ralf Ficner) as follows: pEGFP-DDX23WT was constructed by ligating XhoI+XbaI digested 
pET21a(+)-DDX23 insert fragment into NheI+XhoI digested pEGFP-N1 vector. In order to make 
pEGFP-DDX23PhosM, a 715b fragment with nine mutations (S23D, S49D, S57D, S59D, S61D, 
S63D, S65D, S106D, S118D) and NheI and Van91I sites was synthetically constructed using 
GeneArt
TM
 technologies and cloned into pEGFP-DDX23WT. Similarly for pEGFP-DDX23PhosIA, 
a 715b fragment with nine mutations (S23A, S49A, S57A, S59A, S61A, S63A, S65A, S106A, 
S118A) and NheI and Van91I sites was synthetically constructed using GeneArt
TM
 technologies 
and cloned into pEGFP-DDX23WT. pEGFP-DDX23PhosM was later digested using XcmI and 
self-ligated to get helicase truncated mutant pEGFP-DDX23PhosM∆Hel. Plasmids were 
transfected with supplier’s protocol from Lipofectamine 3000 (Invitrogen). RNaseH1-mCherry 
expression was induced with 2.5 μg/ml doxycycline (Sigma, St Louis, MI). The list of all plasmids 
used in this study is shown in Material and Methods Table 1. 
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Western blot and sub-cellular fractionation 
Whole cell protein extracts were prepared by cell lysis with SDS-PAGE buffer (80 mM Tris-HCL 
pH 6.8, 16% glycerol, 4.5% SDS, 450 mM DTT, 0.01% bromophenol blue) with 200 U/ml 
benzonase (Sigma) and 50 μM MgCl2 and boiling for 5 min. For cellular fractionation, U-2OS were 
swelled and fractioned to separate cytosolic fraction and nuclei (De Almeida et al., 2010). Whole 
nuclei were then lysed in RIPA buffer (50 mM Tris pH=8.0, 150 mM NaCl, 1% NP-40, 0.5% 
Sodium deoxycholate, 0.1% SDS) and centrifuged for 10 min at 15000 rpm to isolate all the 
nucleoplasmic proteins. The chromatin fraction was digested with 20U DNase I. Proteins from the 
different fractions were precipitated using standard trichloro acetic acid-acetone method (TCA-
acetone method). Equal amounts of protein extracts were resolved by SDS-polyacrylamide gel 
electrophoresis (SDS-PAGE) and transferred to a nitrocellulose membrane. Details of antibodies 
used are mentioned in Material and Methods Table 1. 
 
Isolation of chromatin with RNase A digestion  
Nuclei from HeLa cells were isolated as previously described (De Almeida et al., 2010). Briefly, 
HeLa cells were swelled and fractioned to separate cytosolic fraction and nuclei. Whole 
nuclei were re-suspended in 1X RNase reaction buffer (20 mM Tris-HCl (pH=8.4), 50 mM KCl, 5 
mM MgCl2, 20mM DTT) and divided into two halves. One half was digested with 1.5U RNase A 
(Roche) for 90min at 37
0
C and another with buffer alone. RNase A  digested and undigested nuclei 
were re-suspended  (5% Glycerol, 20mM Tris (pH=7.9), 75mM NaCl, 0.5mM EDTA, 0.85mM 
DTT, 0.125mM PMSF) and lysed (20mM HEPES (pH=7.6), 300mM NaCl, 0.2mM EDTA, 1mM 
DTT, 7.5mM MgCl2, 1M Urea, 1% NP40) on ice for 10min. The samples were centrifuged for 10 
min at 15000 rpm to isolate chromatin. The step is repeated to isolate pure chromatin. The 
chromatin fraction was digested with 20U DNase I. Proteins from different fractions were 
precipitated using the standard TCA-acetone method. Equal amounts of protein extracts were 
resolved by SDS-PAGE and transferred to a nitrocellulose membrane. Details of antibodies used 
are mentioned in Material and Methods Table 1. 
 
Immunofluorescence 
U-2OS cells grown on coverslips were fixed with 3.7% paraformaldehyde for 10 min at room 
temperature. The cells were then permeabilized with 0.5% Triton X-100/PBS for 10 min and 
Materials and Methods 
 
                Appendix A. 89 
 
incubated with primary antibodies against γH2AX, cyclin A, SRPK1 and SRPK2  (Carvalho et al., 
2014). R-loops were detected with the S9.6 antibody following cell fixation and permeabilization 
with 100% ice-cold methanol and acetone for 10 min and 1 min on ice. Incubation with primary 
antibodies was followed by incubation with fluorochrome-conjugated secondary antibodies. All the 
washing steps were done with PBS containing 0.05% (v/v) Tween 20. The samples were mounted 
in Vectashield (Vector Laboratories, Burlingame, CA) with 4'-6-diamidino-2-phenylindole (DAPI) 
(Sigma-Aldrich) to stain the DNA. Images were taken using a Zeiss LSM 710 (Carl Zeiss, 
Oberkochen, Germany) confocal microscope with a 63x/1.4 oil immersion and quantified with 
Image J. List of primary and secondary antibodies used are mentioned in Material and Methods 
Table 1. 
 
Analysis of metaphase spreads 
Metaphases were prepared from HeLa cells as described (Gallego-Paez et al., 2014) with the 
following modifications. Briefly, five days after RNAi cells were synchronized with 1mM 
thymidine (Sigma) for 20 hours and released from thymidine block for 6 hours. Cells were then 
treated with 1μg/ml nocodazole (Sigma) for 2 hours and mitotic cells were collected by mitotic 
shake. Cells were then centrifuged and re-suspended in pre-warmed 75 mM KCl for 5 min and 
fixed with freshly prepared ice-cold Carnoy’s solution (3:1 methanol:acetic acid solution). Fixed 
chromosomes were washed and re-suspended in Carnoy’s solution. Chromosomes were then 
dropped on clean glass side, dried and stained with Giemsa (Millipore). Excess Giemsa stain was 
washed with distilled water and glass slides were dried. Dried chromosome spreads were mounted 
using Fluoromount-G medium (Southern Biotech, Birmingham, AL, USA). Randomly selected 
metaphase spreads were imaged using 100X oil immersion (Leica DM2500 microscope). 
Chromosomal aberrations were quantified on three independent experiments. At least 20 
metaphases per condition were analyzed on each independent experiment  
 
Cell cycle analysis  
The nuclear DNA content was estimated by flow cytometry analysis of cells stained with  
propidium iodide (PI) as described earlier (Carvalho et al., 2014). Briefly, U2-OS cells transfected 
with RNase H1-GFP or treated with triptolide were collected by trypsinization and fixed by drop-
wise addition of ice-cold 50% ethanol with gentle vortexing followed by RNA digestion and 
addition of PI (100 μg/ml). Acquisition of cells transfected with RNase H1-GFP was performed on 
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a FACS Calibur (BD Biosciences) and acquisition of cells treated with triptolide was performed on 
a BD Accuri C6 (BD Biosciences). Data was processed with FlowJo (TreeStar).  
 
Co-Immunoprecipitation 
Co-immunoprecipitations of RNA Pol II with SRPKs were performed on nuclei extracts as 
described (Carvalho et al., 2014). Briefly, isolated nuclei were lysed (20 mM Hepes pH 7.0, 10 
mM KCl, 0.1% (v/v) NP40, 6 mM MgCl2, 20% (v/v) glycerol, protease-(Roche) and phosphatase 
inhibitors (Roche) for 10mins on ice. Then nuclei were sonicated with a single pulse of 15 s at 20% 
intensity using a Soniprep150 and digested with 20U DNase I (Roche) at 4°C for 60 min before 
pre-clearing with Protein G Dynabeads (Life Technologies) at 4°C for 30 min. 1µg of DNase I 
digested DNA was run on 1% agarose gel to check if DNA is fragmented in the given conditions 
(Extended Data Fig.2d). Samples were diluted in IP buffer (20 mM Hepes pH 7.0, 10 mM KCl, 
1.5 mM MgCl2, 0.2%(v/v) Tween20, 10% (v/v) glycerol, 1 mM DTT) and incubated with 
respective antibodies overnight at 4°C. The protein complexes were pulled down using Protein G 
Dynabeads for 2h at 4°C, washed one time in wash buffer (20 mM Hepes pH 7.0, 50 mM KCl, 1.5 
mM MgCl2, 0.2% (v/v) Tween20, 10% (v/v) glycerol, 1 mM DTT) with increasing KCl 
concentrations of 50 mM, 100mM and 150 mM. The final wash was made in IP buffer. Protein 
samples were then eluted in 2X Laemmli buffer and resolved by SDS-PAGE before 
immunobloting. 1/10th of the total cell lysate was used as input samples. Overexpressed DDX23-
WT or DDX23-PhosM-ΔHel proteins were immunoprecipitated from U2-OS whole-cell lysates 
with a T7 antibody (Millipore, AB3790). Before sonication, cells were cross-linked for 5 min with 
1% formaldehyde followed by quenching with 1M glycine. Pulled down complexes were resolved 
by western blot. List of antibodies used are mentioned in Material and Methods Table 1. 
 
DRIP 
DNA-RNA hybrids were immunoprecipitated as described earlier (Ginno et al., 2012) with 
following modifications. Briefly, U2-OS cells transfected with control, DDX23 and THOC1 RNAi 
were collected after 72hr and lysed in lysis buffer (100 mM NaCl, 10 mM Tris pH 8.0, 25 mM 
EDTA pH 8.0, 0.5% SDS, 50µg/ml Proteinase K) for 5hr at 45
0
C. Nucleic acids were extracted 
using standard phenol-chloroform extraction protocol and re-suspended in DNase/RNase-free 
water. Nucleic acids were then fragmented using restriction enzyme cocktail (20U each of EcoRI, 
BamHI, HindIII, BsrgI and XhoI). Half of the sample was digested with 40U RNase H (NZYtech) 
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to serve as a negative control, for about 36-48hr at 37
0
C. Digested nucleic acids were cleaned with 
standard phenol-chloroform extraction method and res-suspended in DNase/RNase-free water. 
DNA-RNA hybrids were immunoprecipitated from the total nucleic acids using 6.5µg of S9.6 
antibody in binding buffer (10 mM NaPO4 pH 7.0, 140 mM NaCl, 0.05% Triton X-100) overnight 
at 4
0
C. 50µl Protein A/G magnetic beads (Pierce™, Thermo scientific) were used to pull down the 
immunoprecipitates at 4
0
C for 2-3hrs. Pulled-down complexes were washed twice with binding 
buffer, once using TE buffer each for 15min at RT, followed by elution (50 mM Tris pH 8.0, 10 
mM EDTA, 0.5% SDS, 2.5µg proteinase k) for 30 min at 55
0
C. Nucleic acids were extracted using 
phenol-chloroform method. Restriction enzyme digested nucleic acid material was used as input. 
The relative occupancy of the immunoprecipitated DNA-RNA hybrids at each locus was estimated 






 are mean threshold cycles of RT-qPCR done 
in duplicate on samples from input and immunoprecipitations, respectively. The sequence of the 
primers is shown Material and Methods Table 1. 
 
RNA isolation and quantitative RT-PCR 
RNA isolation and cDNA preparation was made as described earlier (Grosso et al., 2015). Briefly, 
total RNA was isolated from U2-OS cells transfected with control or THOC1 siRNAs for 48h 
using TRIzol (Invitrogen). cDNA was made using Superscript II Reverse Transcriptase 
(Invitrogen). RT-qPCR was performed in the ViiA Real Time PCR (Applied Biosystems, CA, 
USA), using SYBR Green PCR master mix (Bio-Rad). The relative RNA expression was estimated 
as follows: 2
(Ct reference – Ct sample)
, where Ct reference and Ct sample are mean threshold cycles of RT-
qPCR done in duplicate of the U6 snRNA (reference) and the gene of interest (sample). All primer 
sequences are presented in Material and Methods Table 1. 
 
ChIP-qPCR and ChIP-seq 
Chromatin immunoprecipitation (ChIP) was performed in U-2OS cells as described (de Almeida et 
al., 2011; Carvalho et al., 2013). Antibodies used for ChIP were mentioned in Material and 
Methods Table 1. The relative occupancy of the immunoprecipitated protein at each DNA locus 
was estimated by RT-qPCR as follows: 2
(Ct Input − Ct IP)
, where Ct Input and Ct IP are mean threshold 
cycles of RT-qPCR done in duplicate on DNA samples from input and specific 
immunoprecipitations, respectively. The sequence of the primers is shown in Material and 
Methods Table 1. ChIP-seq was performed as described (de Almeida et al., 2011). Briefly, ~80% 
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confluent non-transformed human mammary epithelial cells (MCF10A), were incubated with 1% 
(v/v) formaldehyde for 10 min to perform cross-linking and quenched with 250 mM glycine for 5 
min. Cells were lysed and sonicated to shear chromatin to get 100-300bp fragments. 1µg of input 
DNA was run on 1% agarose gel to check if most of the fragmented DNA lie within the range of 
100-300bp. Pre-cleared chromatin was incubated separately with antibodies against SRPK1 




 of the 
sample was taken aside as inputs. Immunoprecipitated and input DNA were subsequently purified 
and quantified. For biological replicates, all steps were repeated using independent samples. 
Libraries were prepared with DNA from two biological replicates according to the Illumina 
protocol and sequenced at the GeneCore genomics service center at the EMBL. 
 
Bioinformatics Analyses 
RNA-seq, GRO-seq and RNA Pol II ChIP-seq data for MCF10A were obtained from the Sequence 
Read Archive (RNA-seq: SRX685939; GRO-seq: ERR034678, ERR039508, ERR039509; RNA 
Pol II ChIP-seq: SRX143301). The quality of HTS data was assessed with FastQC 
(www.bioinformatics.babraham.ac.uk/projects/fastqc). ChIP-seq reads were aligned to the 
reference human genome (GRCh37/hg19 assembly) with Bowtie (Langmead et al., 2009) and 
filtering for uniquely aligned reads. Enriched regions were identified for each individual replicate 
using MACS (Zhang et al., 2008), with a false-discovery rate of 0.05. Only genomic regions 
consistently identified between biological replicates were considered for downstream analyses. 
Finally, ChIP-seq enriched regions were assigned to annotated genes, including a 4 kb region 
upstream the transcription start site and downstream the transcription termination site (Extended 
Data Table 1). Gene annotations were obtained from Ensembl (GRCh37.75 version (Flicek et al., 
2014)) and merged into a single transcript model per gene using BedTools (Quinlan and Hall, 
2010). For individual and metagene profiles, uniquely mapped reads were extended in the 3’ 
direction to reach 150 nucleotides with the Pyicos (Althammer et al., 2011). For the metagene 
profile, genes were aligned at the first and last nucleotides of the annotated transcripts and read 
counts were scaled as follows: the 5’ end (10 kb upstream of the transcription start site) and the 3’ 
end (10 Kb downstream of the transcription termination site) were unscaled and averaged in a 100 
bp window, and the remainder of the gene was represented by 200 values from cubic spline 
interpolation so that all genes seem to have the same length. Individual profiles were produced 
using a 20 bp window. All profiles were plotted on a normalized reads per kb per million mapped 
reads (RPKMs). Expression levels (TPMs) from RNA-seq and GRO-seq datasets were obtained 
using Kallisto (Bray et al., 2016). Transcriptionally active genes were defined as those with 
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expression levels higher than the 25th percentile.  
GC features were assessed for genic SRPK1 and SRPK2 binding sites co-oriented with 
transcription and recovered 2 kb of DNA sequence on each side of the peak summit. GC skew 
(calculated using the formula (G-C)/(G+C)) and CpG density (measured as the CpG observed 
versus expected ratio or CpG o/e) were computed for 50 bp sliding windows of 1 bp step size. The 
random peak dataset was generated using the shuffle Bedtools function, by permutating the SRPK2 
peaks (maintaining the number and length) from annotated genes.  
Point-mutations in DDX23 were obtained from cBioportal (Gao et al., 2013) their effect was 
predicted using PredictSNP (Bendl et al., 2016) (Extended Data Table 2). 
A set of in-house scripts for data processing and graphical visualization were written in bash and in 
the R environmental language http://www.R-project.org. SAMtools (Li et al., 2009) and BED tools 
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Drugs                       Final concentration  
 
Triptolide 500nM/70min Santa Cruz; sc-200122 To inhibit RNA Pol II transcription inhibiton 
Nocodazole 1µg/ml  Sigma-Aldrich; M1404 To arrest cells in mitotic phase 
Doxycycline 2.5µg/ml for 48hr Sigma-Aldrich; D9891 To induce RNaseH1-mCherry plasmid 
    
siRNA 
 
Control siRNA  10µM/48-72hr Eurogentec siRNA against fire fly luciferase locus 
Sense: CGUACGCGGAAUACUUCGA 
Anti-sense: UCGAAGUAUUCCGCGUACG 
SRPK1 siRNA 10µM/48-72hr Santa Cruz; sc-39235 To deplete SRPK1 transiently 




To deplete SRPK2 transiently 




To deplete DDX23 transiently 
THOC1 siRNA 10µM/48-72hr Santa Cruz; sc-76652 To deplete THOC1 transiently 
PRP8 siRNA 10µM/48-72hr Santa Cruz; sc-38209 To deplete PRP8 transiently 
PRP6 siRNA 10µM/48-72hr Qiagen;  SI03101945, 
SI05021646 





pEGFP-RNaseH1 48hr Provided by Dr. Robert J 
Crouch 
Bacterial RNaseH1 tagged with GFP 
pICE-RNaseHI-
mCherry 
48hr Provided by Dr. Patrick 
Calsou 
Bacterial RNaseH1 tagged with mCherry 
inducible by doxycycline. 
pCGT-SRSF1WT 48hr Provided by Dr. Javier 
Caceres 
Human SRSF1 wild type tagged with T7. 
pCGT-
SRSF1PhosM 
48hr Provided by Dr. Javier 
Caceres 
Human SRSF1 phosphomimic mutant tagged with 
T7. 
pEGFP-DDX23WT 48hr Self made with advice 
from Dr. Robert Martin 




48hr Self made with  advice 
from Dr. Robert Martin 
Human DDX23 phosphomimic mutant, tagged 
with T7 and GFP. 
pEGFP-
DDX23PhosIA 
48hr Self made with  advice 
from Dr. Robert Martin 
Human DDX23 phospho inactive mutant, tagged 
with T7 and GFP. 
pEGFP-
DDX23PhosM∆Hel 
48hr Self made with  advice 
from Dr. Robert Martin 
Human DDX23 phosphomimic mutant  with 
helicase truncation, tagged with T7 and GFP. 
    
Antibodies 
 
S9.6 1µg/25µl (IF), 
6.5µg/IP  
Kerafast; ENH001 RNA-DNA hybrid antibody used to detect R-
loops 
γH2AX 1:2500 (WB), 1:200 
(IF) 
Millipore; 05-636  Serine 139 phosphorylated H2AX, DNA damage 
marker 
SRPK1 1:2000 (WB), 1:200 
(IF), 2-4µg/IP 
Abcam; ab90527 
BD Bioscience; 611072 
Serine-Arginine protein kinase 1 specific antibody 
SRPK2 1:2000 (WB), 1:200 
(IF), 2-4µg/IP 
BD Bioscience; 611118 
Bethyl Laboratory; 
A302-467A 
Serine-Arginine protein kinase 2 specific antibody 
DDX23 1:500 (WB), 2-
3µg/IP 
Santa Cruz; sc-133504 DEAD box helicase 23 specific antibody 
THOC1 1:1000 (WB) Genetex; GTX70220  THO complex 1 specific antibody 
RNA Pol II (N20) 1:200 (WB), 3µg/IP Santa Cruz; sc-899 Total RNA Pol II antibody 
Ser5P-RNA Pol II 1:250 (WB), 50µl/IP Provided by Prof. Carmo 
Fonseca’s  lab 
Serine 5 phoshorylated RNA Pol II antibody 
Ser2P-RNA Pol II 50µl/IP Provide by Prof. Carmo 
Fonseca’s lab 
Serine 2 phoshorylated RNA Pol II antibody 
Material and Methods Table 1. 
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SRSF1 1:500 (WB) Provided by Dr. Adrian 
Krainer’s lab 
SRSF1 specific antibody 
GFP 1:1000 Roche; 1181446000 To detect GFP (green fluorescent protein) tagged 
proteins (here DDX23) 
U1A-30K 1:1000 (WB) Abcam; ab55751 Splicing factor, here used as a control for RNase 
A digestion 
Cyclin A 1:200 (IF) Santa Cruz; sc-751 Marker for replicating cells 
T7 1:200 (IF) 
3µg/IP 
Millipore;  AB3790 To detect T7 tagged proteins (here SRSF1 and 
DDX23) 
α-tubulin 1:10000 (WB) Sigma-Aldrich; T5168 Loading control in immunoblots 
H3 1:1000 (WB) Abcam; ab1791 Loading control in immunoblots 
Histone H2A 1:1000 (WB) Abcam; ab18255 Loading control in immunoblots 
Histone H2B 1:1000 (WB) Abcam; ab1790 Loading control in immunoblots 
Cy3 anti-mouse 1:200 (IF) Bethyl; A90-516C3 secondary antibodies used in immunofluorescence 
Cy3 anti- rabbit  1:200 (IF) Bethyl; A120-201C3  secondary antibodies used in immunofluorescence 
Dy 488 anti-mouse 1:200 (IF) Bethyl; A90-244D2 
 
secondary antibodies used in immunofluorescence 
    
Primers 
 
APOE  10µM Sequences provided by 
Bhatia et al., 2014 
Made by Life 
Technologies 
APOE R-loop primer 
Fw: CCGGTGAGAAGCGCAGTCGG 
Rv: CCCAAGCCCGACCCCGAGTA 
Self designed & made by 
Life Technologies 
Primers to check APOE mRNA levels  
Fw: GGCAGAGCGGCCAGCG 
Rv: CTCCTCCTGCACCTGCTC 
ACTB  10µM Sequences provided by 
Skourti-Stathaki et al., 
2011 
Made by Life 
Technologies 





Self designed & made by 
Life Technologies 
Primers to check ACTB mRNA levels  
Fw:GGAGGAGCTGGAAGCAGC 
Rv:CTGGCCGGGACCTGACT 
SNRPN 10µM Sequences provided by 
Bhatia et al., 2014 
Made by Life 
Technologies 
SNRPN R-loop negative locus  
Fw: TGCCAGGAAGCCAAATGAGT 
Rv: TCCCTCTTGGCAACATCCA 
Self designed & made by 
Life Technologies 
Primers to check SNRPN mRNA levels  
Fw:GTAATTGGGACTCCCATCAAG 
Rv:GAGAAGTGCCCCACGTGG 
PRP6 10µM Self designed & made by 
Life Technologies 
Primers to check PRP6 mRNA levels  
Ex9 Fw  GATGTCTGGCTGGAAGCAG 
Ex9 Rv  GCTCACCTTTCCGAAGAACC 
Ex6 Fw GCAATTTGGAGGTCTTAACACA 
Ex6 Rv  GCCTCATGTCCATCAGAGTG 
RBM15 10µM Self designed & made by 
Life Technologies 
SRPK1 ChIP-qPCR primers 
Fw CCTCCGTTATACAGGCCTAC    
Rv AGAGGCAGGCTCACAGCG    
MRP63 10µM Self designed & made by 
Life Technologies 
SRPK1 ChIP-qPCR primers 
Fw CACAGCCTCCCGCCACTA    
Rv CTGCCGCGCTGCTCAAG    
ECHS1 10µM Self designed & made by 
Life Technologies 
SRPK1 ChIP-qPCR primers 
Fw GCGTGCAGGTCGGAGTCAGGA   
Rv CCGGGCGAGGAGTCCAGAG   
NDRG3 10µM Self designed & made by 
Life Technologies 
SRPK2 ChIP-qPCR primers 
Fw GAGCTCTGTACCTGGGTGA    
Rv CCAGGGGACGAACTTGGA 
ERO1B 10µM Self designed & made by 
Life Technologies 
SRPK2 ChIP-qPCR primers 
Fw  AGTGCTGGGATTACGGTGTAA   
Rv AGCTCCTCAGTGGAAAGTGA  
SENP5 10µM Self designed & made by 
Life Technologies 
SRPK2 ChIP-qPCR primers 
Fw  GGCGGATCACAAGGTCAG   
Rv TGAATGGAATCGTCATCG ATGA   
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*WB, Western blot; IF, Immunofluorescence; IP, Immunoprecipitation or chromatin immunoprecipitation. 
**This list contains details of reagents more specific for this study. More general reagents used have been 











































We read the world wrong and say that it deceives us. 
Tagore 
 
The adventurous student will always study classics…. it requires training such as the athletes underwent the 
steady intention almost of the whole life to this object. Books must be read as deliberately and reservedly as 
they were written. 
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It is very simple to be happy, but it is very difficult to be simple. 
Tagore 
 
It’s not what you look that matters, it’s what you see. 
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Abbreviations   
∆Hel Helicase truncation 
µm Microns 
53BP1 p53-binding protein 1  
ACC Adenoid cystic carcinoma  
ACTB β-actin locus 
AGS Aicardi-Goutières Syndrome  
AKT Protein Kinase B 
ALS Amyotrophic lateral sclerosis 
APOE Apolipoprotein E locus 
AQR Aquarius helicase 
ATP Adenosine triphosphate 
bp Base pairs 
C.elegans Caenorhabditis elegans 
CAN Copy number alterations 
CpG Cytosine base followed immediately by a Guanine base 
CTD-RNA Pol II C-terminal domain of RNA polymerase II 
DDX23 DEAD box helicase 23 
DNA Deoxyribonucleic acid 
DNMT3B1 DNA cytosine-5 methyltransferase 3b isoform 1 
DRIP/DRIP-seq DNA-RNA immunoprecipitation/DNA-RNA immunoprecipitation 
sequencing 
DSB(s) DNA double strand break(s) 
dsDNA Double stranded DNA 
dsRNA Double stranded RNA 
FACT FAcilitates Chromatin Transcription complex  
FMR1 Fragile X mental retardation 1 locus  
G4-DNA G-quadraplex DNA 
GRO-seq Global Run-on sequencing 
H2A Histone 2A 
H2B Histone 2B 
H3 Histone 3 
H3K36me3  Trimethylation of lysine 36 of histone H3  
H3K9me3 Dimethylation of lysine 9 of histone H3  
HeLa Cervical adenocarcinoma cells 
kb Kilobases 
Kda Kilo Daltons 
mRNA Messenger RNA 
ncRNA(s) Non-protein coding RNA(s) 
PAS Poly-adenylation sites  
PhosIA Phospho inactive 
PhosM Phosphomimetic 
RNA  Ribonucleic acid 
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RNA Pol I/II/III RNA Polymerase I, RNA Polymerase II, RNA Polymerase III 
RNAi RNA interference  
RNA-seq RNA sequencing 
RNP Ribonucleoprotein 
RPA Replication protein A 
RPKMs Reads per kb per million mapped reads  
S.cerevisiae Saccharomyces cerevisiae 
S.Pombe Schizosaccharomyces pombe 
Sen1/SETX Senataxin helicase 
Ser5p RNA Pol II Serine 5 phosphorylated RNA polymerase II 
SETD2 SET Domain Containing 2 
siRNA(s) small interfering RNA(s) 
snRNA(s) Small nuclear RNA(s) 
snRNP(s) Small nuclear ribonucloprotein particle(s) 
SNRPN Small Nuclear Ribonucleoprotein Polypeptide N locus 
SR protein Serine/arginine group of proteins 
SRPK1 Serine/arginine protein kinase 1  
SRPK2 Serine/arginine protein kinase 2 
SRSF1 (or 
ASF/SF2) 
Serine/arginine splicing factor 1  
SSB(s) DNA single strand break(s) 
ssDNA Single stranded DNA 
THO/TREX TRanscription EXport complex  
THOC1 THO complex 1 
Tip60 Histone acetyltransferase KAT5 
TOP1 Human topoisomerase 1 
TPMs Transcripts per million 
U1 snRNP U1 Small nuclear ribonucloprotein particle(s) 
U2-OS Osteosarcoma cells 
U4/U6.U5 tri-
snRNP  
U4/U6.U5 tri-Small nuclear ribonucloprotein particle(s) 
U5 snRNP U5 Small nuclear ribonucloprotein particle(s) 
UV Ultraviolet light 
WT Wild type 
XRN2/Xrn2/Rat1 5’-3’ exoribonuclease 2  
γH2AX Serine 139 phosphorylated histone 2A variant x 
ChIP/ChIP-seq Chromatin immunoprecipitaion/chromatin immunoprecipitation 
sequencing 
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I meant what I said. If I could have said it any differently, I would have! 
Eliot 
 
Here is a chemical reaction; four years of life, turmoil, sweat, passion, hardships and love; boiled in a vessel 
with flesh, bones, muscle and so called soul, chilled over time; yielding not even four kilograms of bound 
paper! Here it is! 
Anonymous 
 
As for the thesis itself — a slim, red volume with gold lettering — it's not something she feels sentimental 
about. “I've met people who, they cry when they give away their kids' baby clothes, but I was never one of 
those — and I think I felt the same way about the thesis.” She's more inclined to look forward. “In exoplanets, 
the best planet, the best discovery, is the next discovery.” 
Sara Seager 
 
All good things must come to an end, and when the time comes to make my exit, I hope I can do so with good 
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